BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146:67-75.e5. [PMID: 24076059 DOI: 10.1053/j.gastro.2013.09.046] [Cited by in Crossref: 659] [Cited by in F6Publishing: 630] [Article Influence: 73.2] [Reference Citation Analysis]
Number Citing Articles
1 Yeşilyurt N, Yılmaz B, Ağagündüz D, Capasso R. Microbiome-based personalized nutrition as a result of the 4.0 technological revolution: A mini literature review. Process Biochemistry 2022;121:257-62. [DOI: 10.1016/j.procbio.2022.07.012] [Reference Citation Analysis]
2 Huang H, Zhu J, Yang L, Wu Q, Shou D, Chen H, Ma J, Li Y, Xu H, Zhou Y, Aqib AI. Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea. Oxidative Medicine and Cellular Longevity 2022;2022:1-24. [DOI: 10.1155/2022/5121496] [Reference Citation Analysis]
3 Rej A, Avery A, Aziz I, Black CJ, Bowyer RK, Buckle RL, Seamark L, Shaw CC, Thompson J, Trott N, Williams M, Sanders DS. Diet and irritable bowel syndrome: an update from a UK consensus meeting. BMC Med 2022;20:287. [PMID: 36096789 DOI: 10.1186/s12916-022-02496-w] [Reference Citation Analysis]
4 Moshiree B, Heidelbaugh JJ, Sayuk GS. A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers. Adv Ther. [DOI: 10.1007/s12325-022-02224-z] [Reference Citation Analysis]
5 Gasche R. Dietitians: roles in the community and contribution to patient care. Br J Community Nurs 2022;27:336-40. [PMID: 35776564 DOI: 10.12968/bjcn.2022.27.7.336] [Reference Citation Analysis]
6 Biesiekierski JR, Manning LP, Murray HB, Vlaeyen JWS, Ljótsson B, Van Oudenhove L. Review article: Exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome. Aliment Pharmacol Ther 2022. [PMID: 35775328 DOI: 10.1111/apt.17111] [Reference Citation Analysis]
7 Peters SL, Muir JG, Gibson PR. Letter: progressive weakening of the concept that gluten has a detrimental effect on mental health and gut symptoms in the absence of coeliac disease. Aliment Pharmacol Ther 2022;56:363-4. [PMID: 35748844 DOI: 10.1111/apt.16963] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Halmos EP, Gibson PR. Letter: gut-brain axis dysfunction underlies symptom generation in irritable bowel syndrome-a plea for rational interpretation of irrational doses of FODMAPs. Aliment Pharmacol Ther 2022;56:366-7. [PMID: 35748832 DOI: 10.1111/apt.16975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tye-Din JA. Editorial: lack of gastrointestinal symptoms caused by gluten in patients without coeliac disease-time to ditch the 'gluten' from 'non-coeliac gluten sensitivity'. Aliment Pharmacol Ther 2022;56:340-1. [PMID: 35748828 DOI: 10.1111/apt.16951] [Reference Citation Analysis]
10 Tye-Din JA. Review article: Follow-up of coeliac disease. Aliment Pharmacol Ther 2022;56 Suppl 1:S49-63. [PMID: 35815829 DOI: 10.1111/apt.16847] [Reference Citation Analysis]
11 Anderson RP. Review article: Diagnosis of coeliac disease: a perspective on current and future approaches. Aliment Pharmacol Ther 2022;56 Suppl 1:S18-37. [PMID: 35815826 DOI: 10.1111/apt.16840] [Reference Citation Analysis]
12 Zhang T, Ma X, Tian W, Zhang J, Wei Y, Zhang B, Wang F, Tang X. Global Research Trends in Irritable Bowel Syndrome: A Bibliometric and Visualized Study. Front Med 2022;9:922063. [DOI: 10.3389/fmed.2022.922063] [Reference Citation Analysis]
13 Strisciuglio C, Cenni S, Serra MR, Dolce P, Kolacek S, Sila S, Trivic I, Bar Lev MR, Shamir R, Kostovski A, Papadopoulou A, Roma E, Katsagoni C, Jojkic-pavkov D, Campanozzi A, Scarpato E, Miele E, Staiano A. Diet and Pediatric Functional Gastrointestinal Disorders in Mediterranean Countries. Nutrients 2022;14:2335. [DOI: 10.3390/nu14112335] [Reference Citation Analysis]
14 Singh P, Tuck C, Gibson PR, Chey WD. The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation. Am J Gastroenterol 2022;117:947-57. [PMID: 35435179 DOI: 10.14309/ajg.0000000000001767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Lövdahl J, Törnblom H, Ringström G, Palsson OS, Simrén M. Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome. Aliment Pharmacol Ther 2022;55:1501-11. [PMID: 35505463 DOI: 10.1111/apt.16934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut 2022;71:1117-26. [PMID: 34376515 DOI: 10.1136/gutjnl-2021-325214] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
17 Kim SH. Effect of Diet on Irritable Bowel Syndrome. Korean J Gastroenterol 2022;79:231-2. [DOI: 10.4166/kjg.2022.067] [Reference Citation Analysis]
18 Peng Z, Yi J, Liu X. A Low-FODMAP Diet Provides Benefits for Functional Gastrointestinal Symptoms but Not for Improving Stool Consistency and Mucosal Inflammation in IBD: A Systematic Review and Meta-Analysis. Nutrients 2022;14:2072. [DOI: 10.3390/nu14102072] [Reference Citation Analysis]
19 Narayana V, McMeans AR, Levy RL, Shulman RJ, Chumpitazi BP. Children with functional abdominal pain disorders successfully decrease FODMAP food intake on a low FODMAP diet with modest improvements in nutritional intake and diet quality. Neurogastroenterol Motil 2022;:e14392. [PMID: 35535019 DOI: 10.1111/nmo.14392] [Reference Citation Analysis]
20 Fernández-bañares F. Carbohydrate Maldigestion and Intolerance. Nutrients 2022;14:1923. [DOI: 10.3390/nu14091923] [Reference Citation Analysis]
21 Yao C, Li Y, Luo L, Xie F, Xiong Q, Li T, Yang C, Feng PM. Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China. Dig Dis Sci 2022. [PMID: 35503487 DOI: 10.1007/s10620-022-07500-0] [Reference Citation Analysis]
22 Klonarakis M, Andrews CN, Raman M, Panaccione R, Ma C. Review article: therapeutic targets for the pharmacologic management of coeliac disease-the future beyond a gluten-free diet. Aliment Pharmacol Ther 2022;55:1277-96. [PMID: 35229332 DOI: 10.1111/apt.16846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Carbone F, Van den Houte K, Besard L, Tack C, Arts J, Caenepeel P, Piessevaux H, Vandenberghe A, Matthys C, Biesiekierski J, Capiau L, Ceulemans S, Gernay O, Jones L, Maes S, Peetermans C, Raat W, Stubbe J, Van Boxstael R, Vandeput O, Van Steenbergen S, Van Oudenhove L, Vanuytsel T, Jones M, Tack J; DOMINO Study Collaborators., Domino Study Collaborators. Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute. Gut 2022:gutjnl-2021-325821. [PMID: 35483886 DOI: 10.1136/gutjnl-2021-325821] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Rexwinkel R, Vlieger AM, Saps M, Tabbers MM, Benninga MA. A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified. Eur J Pediatr 2022. [PMID: 35460383 DOI: 10.1007/s00431-022-04459-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Plaidum S, Patcharatrakul T, Promjampa W, Gonlachanvit S. The Effect of Fermentable, Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Meals on Transient Lower Esophageal Relaxations (TLESR) in Gastroesophageal Reflux Disease (GERD) Patients with Overlapping Irritable Bowel Syndrome (IBS). Nutrients 2022;14:1755. [DOI: 10.3390/nu14091755] [Reference Citation Analysis]
26 Ghaffari P, Shoaie S, Nielsen LK. Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03365-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Gu Y, Li L, Yang M, Liu T, Song X, Qin X, Xu X, Liu J, Wang B, Cao H. Bile acid-gut microbiota crosstalk in irritable bowel syndrome. Crit Rev Microbiol 2022;:1-20. [PMID: 35389754 DOI: 10.1080/1040841X.2022.2058353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
28 Weber HC. Irritable bowel syndrome and diet. Curr Opin Endocrinol Diabetes Obes 2022;29:200-6. [PMID: 35131984 DOI: 10.1097/MED.0000000000000720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 De Palma G, Bercik P. Long-term personalized low FODMAP diet in IBS. Neurogastroenterol Motil 2022;34:e14356. [PMID: 35293089 DOI: 10.1111/nmo.14356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Chey WD, Hashash JG, Manning L, Chang L. AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review. Gastroenterology 2022:S0016-5085(21)04084-1. [PMID: 35337654 DOI: 10.1053/j.gastro.2021.12.248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Stróżyk A, Horvath A, Szajewska H. FODMAP dietary restrictions in the management of children with functional abdominal pain disorders: A systematic review. Neurogastroenterol Motil 2022;:e14345. [PMID: 35231146 DOI: 10.1111/nmo.14345] [Reference Citation Analysis]
32 So D, Yao CK, Gibson PR, Muir JG. Evaluating tolerability of resistant starch 2, alone and in combination with minimally fermented fibre for patients with irritable bowel syndrome: a pilot randomised controlled cross-over trial. J Nutr Sci. [DOI: 10.1017/jns.2022.9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Colomier E, Melchior C, Algera JP, Hreinsson JP, Störsrud S, Törnblom H, Van Oudenhove L, Palsson OS, Bangdiwala SI, Sperber AD, Tack J, Simrén M. Global prevalence and burden of meal-related abdominal pain. BMC Med 2022;20:71. [PMID: 35172840 DOI: 10.1186/s12916-022-02259-7] [Reference Citation Analysis]
34 Parfenov AI. Food intolerances and the small intestine. Terapevticheskii arkhiv 2022;94:153-9. [DOI: 10.26442/00403660.2022.02.201364] [Reference Citation Analysis]
35 Roncoroni L, Gori R, Elli L, Tontini GE, Doneda L, Norsa L, Cuomo M, Lombardo V, Scricciolo A, Caprioli F, Costantino A, Scaramella L, Vecchi M. Nutrition in Patients with Inflammatory Bowel Diseases: A Narrative Review. Nutrients 2022;14:751. [DOI: 10.3390/nu14040751] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
36 Serra J. Management of bloating. Neurogastroenterol Motil 2022;:e14333. [PMID: 35143108 DOI: 10.1111/nmo.14333] [Reference Citation Analysis]
37 Ispiryan L, Zannini E, Arendt EK. FODMAP modulation as a dietary therapy for IBS: Scientific and market perspective. Compr Rev Food Sci Food Saf 2022. [PMID: 35122383 DOI: 10.1111/1541-4337.12903] [Reference Citation Analysis]
38 Elhusein AM, Fadlalmola HA. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients: An Updated Systematic Review and Meta-Analysis. Gastroenterol Nurs 2022;45:11-20. [PMID: 35108241 DOI: 10.1097/SGA.0000000000000652] [Reference Citation Analysis]
39 Mohseni F, Agah S, Ebrahimi-daryani N, Taher M, Nattagh-eshtivani E, Karimi S, Rastgoo S, Bourbour F, Hekmatdoost A. The effect of low FODMAP diet with and without gluten on irritable bowel syndrome: A double blind, placebo controlled randomized clinical trial. Clinical Nutrition ESPEN 2022;47:45-50. [DOI: 10.1016/j.clnesp.2021.12.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Giacosa A, Riva A, Petrangolini G, Allegrini P, Fazia T, Bernardinelli L, Peroni G, Rondanelli M. Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis. Nutrients 2022;14:416. [DOI: 10.3390/nu14030416] [Reference Citation Analysis]
41 Colomier E, Van Oudenhove L, Tack J, Böhn L, Bennet S, Nybacka S, Störsrud S, Öhman L, Törnblom H, Simrén M. Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome. Nutrients 2022;14:397. [PMID: 35057578 DOI: 10.3390/nu14020397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Gibson PR, Halmos EP, So D, Yao CK, Varney JE, Muir JG. Diet as a therapeutic tool in chronic gastrointestinal disorders: Lessons from the FODMAP journey. J Gastroenterol Hepatol 2022. [PMID: 34994019 DOI: 10.1111/jgh.15772] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
43 Rastgoo S, Ebrahimi-Daryani N, Agah S, Karimi S, Taher M, Rashidkhani B, Hejazi E, Mohseni F, Ahmadzadeh M, Sadeghi A, Hekmatdoost A. Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management. Front Nutr 2021;8:746703. [PMID: 34977110 DOI: 10.3389/fnut.2021.746703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Makharia G, Gibson PR, Bai JC, Karakan T, Lee YY, Collins L, Muir J, Oruc N, Quigley E, Sanders DS, Tuck C, Yurdaydin C, Le Mair A. World Gastroenterology Organisation Global Guidelines: Diet and the Gut. J Clin Gastroenterol 2022;56:1-15. [PMID: 34860201 DOI: 10.1097/MCG.0000000000001588] [Reference Citation Analysis]
45 Patcharatrakul T, Linlawan S, Plaidum S, Gonlachanvit S. The Effect of Rice vs. Wheat Ingestion on Postprandial Gastroesophageal Reflux (GER) Symptoms in Patients with Overlapping GERD-Irritable Bowel Syndrome (IBS). Foods 2021;11:26. [PMID: 35010152 DOI: 10.3390/foods11010026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Alkalay MJ. Nutrition in Patients with Lactose Malabsorption, Celiac Disease, and Related Disorders. Nutrients 2021;14:2. [PMID: 35010876 DOI: 10.3390/nu14010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
47 Paine P. Review article: current and future treatment approaches for pain in IBS. Aliment Pharmacol Ther 2021;54 Suppl 1:S75-88. [PMID: 34927753 DOI: 10.1111/apt.16550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Dale HF, Johannessen JCH, Brønstad I, Lied GA. Assessment of Markers of Gut Integrity and Inflammation in Non-Celiac Gluten Sensitivity After a Gluten Free-Diet. Int J Gen Med 2021;14:9459-70. [PMID: 34916830 DOI: 10.2147/IJGM.S333078] [Reference Citation Analysis]
49 Nevé BL, Martinez-De la Torre A, Tap J, Ruiz AN, Derrien M, Cotillard A, Faurie JM, Barba E, Mego M, Dornic Q, Butler J, Merino X, Lobo B, Batet FP, Pozuelo M, Santos J, Guarner F, Manichanh C, Azpiroz F. A Fermented Milk Product Containing B. lactis CNCM I-2494 Improves the Tolerance of a Plant-Based Diet in Patients with Disorders of Gut-Brain Interactions. Nutrients 2021;13:4542. [PMID: 34960094 DOI: 10.3390/nu13124542] [Reference Citation Analysis]
50 Schneider E, Sabaté JM, Bouchoucha M, Hercberg S, Touvier M, Benamouzig R, Julia C, Buscail C. Fermentable Oligo-, Di-, and Mono-Saccharides and Polyols (FODMAPs) Consumption and Irritable Bowel Syndrome in the French NutriNet-Santé Cohort. Nutrients 2021;13:4513. [PMID: 34960065 DOI: 10.3390/nu13124513] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
51 Ankersen DV, Weimers P, Bennedsen M, Haaber AB, Fjordside EL, Beber ME, Lieven C, Saboori S, Vad N, Rannem T, Marker D, Paridaens K, Frahm S, Jensen L, Rosager Hansen M, Burisch J, Munkholm P. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial. J Med Internet Res 2021;23:e30291. [PMID: 34904950 DOI: 10.2196/30291] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Sun Y, Chen X, Wang S, Deng M, Xie Y, Wang X, Chen J, Hesketh T. Gluten-free Diet Reduces the Risk of Irritable Bowel Syndrome: A Mendelian Randomization Analysis. Front Genet 2021;12:684535. [PMID: 34899821 DOI: 10.3389/fgene.2021.684535] [Reference Citation Analysis]
53 Layer P, Andresen V, Allescher H, Bischoff SC, Claßen M, Elsenbruch S, Freitag M, Frieling T, Gebhard M, Goebel-Stengel M, Häuser W, Holtmann G, Keller J, Kreis ME, Kruis W, Langhorst J, Jansen PL, Madisch A, Mönnikes H, Müller-Lissner S, Niesler B, Pehl C, Pohl D, Raithel M, Röhrig-Herzog G, Schemann M, Schmiedel S, Schwille-Kiuntke J, Storr M, Preiß JC, Andus T, Buderus S, Ehlert U, Engel M, Enninger A, Fischbach W, Gillessen A, Gschossmann J, Gundling F, Haag S, Helwig U, Hollerbach S, Karaus M, Katschinski M, Krammer H, Kuhlbusch-Zicklam R, Matthes H, Menge D, Miehlke S, Posovszky MC, Schaefert R, Schmidt-Choudhury A, Schwandner O, Schweinlin A, Seidl H, Stengel A, Tesarz J, van der Voort I, Voderholzer W, von Boyen G, von Schönfeld J, Wedel T; Collaborators:., in Zusammenarbeit mit:., Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM)., Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)., Deutsche Gesellschaft für Ernährungsmedizin (DGEM)., Deutsche Gesellschaft für Geriatrie (DGG)., Deutsche Gesellschaft für Innere Medizin (DGIM)., Deutsche Gesellschaft für Naturheilkunde (DGNHK)., Deutsche Gesellschaft für Pathologie und Bundesverband deutscher Pathologen e. V. (DGP/BDP)., Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM)., Deutsche Gesellschaft für Verhaltensmedizin und Verhaltensmodifikation (DGVM)., Deutsche Schmerzgesellschaft e. V., Deutsches Kollegium für Psychosomatische Medizin (DKPM), Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG)., Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE)., Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ)., Swiss Society of Neurogastroenterology and Motility (SwissNGM)., Informationsforum für Patient:innen mit Magen-Darm-Erkrankungen (MAGDA). Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Z Gastroenterol 2021;59:1323-415. [PMID: 34891206 DOI: 10.1055/a-1591-4794] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 Bae E, Kim J, Jang J, Kim J, Kim S, Chang Y, Kim MY, Jeon M, Kang S, Lee JK, Kim TG. Effects of a low-FODMAP enteral formula on diarrhea on patients in the intensive care unit. Nutr Res Pract 2021;15:703-14. [PMID: 34858549 DOI: 10.4162/nrp.2021.15.6.703] [Reference Citation Analysis]
55 Nyyssölä A, Nisov A, Lille M, Nikinmaa M, Rosa-sibakov N, Ellilä S, Valkonen M, Nordlund E. Enzymatic reduction of galactooligosaccharide content of faba bean and yellow pea ingredients and food products. Future Foods 2021;4:100047. [DOI: 10.1016/j.fufo.2021.100047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
56 Schindler V, Hente J, Murray FR, Hüllner M, Becker AS, Giezendanner S, Schnurre L, Bordier V, Pohl D. Adding a liquid test meal to a standardized lactulose hydrogen breath test significantly influences abdominal symptom generation and hydrogen values. Eur J Gastroenterol Hepatol 2021;33:1485-94. [PMID: 34609811 DOI: 10.1097/MEG.0000000000002042] [Reference Citation Analysis]
57 So D, Gibson PR, Muir JG, Yao CK. Dietary fibres and IBS: translating functional characteristics to clinical value in the era of personalised medicine. Gut 2021;70:2383-94. [PMID: 34417199 DOI: 10.1136/gutjnl-2021-324891] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
58 Negrete-romero B, Valencia-olivares C, Baños-dossetti GA, Pérez-armendáriz B, Cardoso-ugarte GA. Nutritional Contributions and Health Associations of Traditional Fermented Foods. Fermentation 2021;7:289. [DOI: 10.3390/fermentation7040289] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Wollny T, Daniluk T, Piktel E, Wnorowska U, Bukłaha A, Głuszek K, Durnaś B, Bucki R. Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome. Pathogens 2021;10:1545. [PMID: 34959500 DOI: 10.3390/pathogens10121545] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Vervier K, Moss S, Kumar N, Adoum A, Barne M, Browne H, Kaser A, Kiely CJ, Neville BA, Powell N, Raine T, Stares MD, Zhu A, De La Revilla Negro J, Lawley TD, Parkes M. Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet. Gut 2021:gutjnl-2021-325177. [PMID: 34810234 DOI: 10.1136/gutjnl-2021-325177] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
61 Singh P, Grabauskas G, Zhou SY, Gao J, Zhang Y, Owyang C. High FODMAP diet causes barrier loss via lipopolysaccharide-mediated mast cell activation. JCI Insight 2021;6:e146529. [PMID: 34618688 DOI: 10.1172/jci.insight.146529] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
62 Fortea M, Albert-Bayo M, Abril-Gil M, Ganda Mall JP, Serra-Ruiz X, Henao-Paez A, Expósito E, González-Castro AM, Guagnozzi D, Lobo B, Alonso-Cotoner C, Santos J. Present and Future Therapeutic Approaches to Barrier Dysfunction. Front Nutr 2021;8:718093. [PMID: 34778332 DOI: 10.3389/fnut.2021.718093] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
63 Ispiryan L, Borowska M, Sahin AW, Zannini E, Coffey A, Arendt EK. Lachancea fermentati FST 5.1: an alternative to baker's yeast to produce low FODMAP whole wheat bread. Food Funct 2021;12:11262-77. [PMID: 34710210 DOI: 10.1039/d1fo01983j] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Thibault R, Abbasoglu O, Ioannou E, Meija L, Ottens-Oussoren K, Pichard C, Rothenberg E, Rubin D, Siljamäki-Ojansuu U, Vaillant MF, Bischoff SC. ESPEN guideline on hospital nutrition. Clin Nutr 2021;40:5684-709. [PMID: 34742138 DOI: 10.1016/j.clnu.2021.09.039] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
65 Okawa Y. Development of colonic transit time and ultrasound imaging tools as objective indicators for assessing abnormal defecation associated with food intake: a narrative review based on previous scientific knowledge. Biopsychosoc Med 2021;15:20. [PMID: 34742336 DOI: 10.1186/s13030-021-00222-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Yang J, Lin GZ, Li XY, Wang YT, Loh YH. Investigating the Role of Low-FODMAP Diet in Improving Gastrointestinal Symptoms in Irritable Bowel Syndrome. Proceedings of Singapore Healthcare. [DOI: 10.1177/20101058211051430] [Reference Citation Analysis]
67 Nordin E, Brunius C, Landberg R, Hellström PM. FODMAPs, but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial. Am J Clin Nutr 2021:nqab337. [PMID: 34617561 DOI: 10.1093/ajcn/nqab337] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
68 Van Ouytsel P, Szalai A, Van Gossum A, Arvanitakis M, Louis H. Feasibility of a low FODMAPs diet without initial dietician intervention in the management of patients with irritable bowel syndrome: a prospective study. Acta Gastroenterol Belg 2021;84:593-600. [PMID: 34965041 DOI: 10.51821/84.4.010] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
69 Van Nieuwenhove T, Rasschaert G, Kharagjitsingh A, Keymeulen B, Reynaert H, Kindt S. The prevalence of disorders of the gut-brain axis in type 2 diabetes mellitus patients with metabolic dysfunction-associated fatty liver disease: an observational study. Acta Gastroenterol Belg 2021;84:541-7. [PMID: 34965034 DOI: 10.51821/84.4.003] [Reference Citation Analysis]
70 Algera JP, Störsrud S, Lindström A, Simrén M, Törnblom H. Gluten and fructan intake and their associations with gastrointestinal symptoms in irritable bowel syndrome: A food diary study. Clin Nutr 2021;40:5365-72. [PMID: 34560607 DOI: 10.1016/j.clnu.2021.09.002] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
71 Ostrowska L, Wasiluk D, Lieners CFJ, Gałęcka M, Bartnicka A, Tveiten D. Igg Food Antibody Guided Elimination-Rotation Diet Was More Effective than FODMAP Diet and Control Diet in the Treatment of Women with Mixed IBS-Results from an Open Label Study. J Clin Med 2021;10:4317. [PMID: 34640335 DOI: 10.3390/jcm10194317] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Thomson C, Garcia AL, Edwards CA. Interactions between dietary fibre and the gut microbiota. Proc Nutr Soc 2021;:1-11. [PMID: 34551829 DOI: 10.1017/S0029665121002834] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
73 Wang J, Yang P, Zhang L, Hou X. A Low-FODMAP Diet Improves the Global Symptoms and Bowel Habits of Adult IBS Patients: A Systematic Review and Meta-Analysis. Front Nutr 2021;8:683191. [PMID: 34490319 DOI: 10.3389/fnut.2021.683191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
74 Turan B, Bengi G, Cehreli R, Akpınar H, Soytürk M. Clinical effectiveness of adding probiotics to a low FODMAP diet: Randomized double-blind placebo-controlled study. World J Clin Cases 2021; 9(25): 7417-7432 [PMID: 34616808 DOI: 10.12998/wjcc.v9.i25.7417] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 McGowan A, Harer KN. Irritable Bowel Syndrome and Eating Disorders: A Burgeoning Concern in Gastrointestinal Clinics. Gastroenterol Clin North Am 2021;50:595-610. [PMID: 34304790 DOI: 10.1016/j.gtc.2021.03.007] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
76 Staudacher HM, Rossi M, Kaminski T, Dimidi E, Ralph FSE, Wilson B, Martin LD, Louis P, Lomer MCE, Irving PM, Whelan K. Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterol Motil 2021;:e14241. [PMID: 34431172 DOI: 10.1111/nmo.14241] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
77 Tiffany CR, Lee JY, Rogers AWL, Olsan EE, Morales P, Faber F, Bäumler AJ. The metabolic footprint of Clostridia and Erysipelotrichia reveals their role in depleting sugar alcohols in the cecum. Microbiome 2021;9:174. [PMID: 34412707 DOI: 10.1186/s40168-021-01123-9] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
78 Rogers CC, Moutinho TJ Jr, Liu X, Valdez RS. Designing Consumer Health Information Technology to Support Biform and Articulation Work: A Qualitative Study of Diet and Nutrition Management as Patient Work. JMIR Hum Factors 2021;8:e27452. [PMID: 34383664 DOI: 10.2196/27452] [Reference Citation Analysis]
79 Barber C, Mego M, Sabater C, Vallejo F, Bendezu RA, Masihy M, Guarner F, Espín JC, Margolles A, Azpiroz F. Differential Effects of Western and Mediterranean-Type Diets on Gut Microbiota: A Metagenomics and Metabolomics Approach. Nutrients 2021;13:2638. [PMID: 34444797 DOI: 10.3390/nu13082638] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
80 Laurent J, Struyf N, Bautil A, Bakeeva A, Chmielarz M, Lyly M, Herrera-malaver B, Passoth V, Verstrepen KJ, Courtin CM. The Potential of Kluyveromyces marxianus to Produce Low-FODMAP Straight-Dough and Sourdough Bread: a Pilot-Scale Study. Food Bioprocess Technol 2021;14:1920-35. [DOI: 10.1007/s11947-021-02681-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Tuck CJ, Malakar S, Barrett JS, Muir JG, Gibson PR. Naturally-occurring dietary salicylates in the genesis of functional gastrointestinal symptoms in patients with irritable bowel syndrome: Pilot study. JGH Open 2021;5:871-8. [PMID: 34386594 DOI: 10.1002/jgh3.12578] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
82 Hahn J, Choi J, Chang MJ. Effect of Low FODMAPs Diet on Irritable Bowel Syndromes: A Systematic Review and Meta-Analysis of Clinical Trials. Nutrients 2021;13:2460. [PMID: 34371973 DOI: 10.3390/nu13072460] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
83 Naseri K, Dabiri H, Rostami-Nejad M, Yadegar A, Houri H, Olfatifar M, Sadeghi A, Saadati S, Ciacci C, Iovino P, Zali MR. Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. BMC Gastroenterol 2021;21:292. [PMID: 34261437 DOI: 10.1186/s12876-021-01868-5] [Reference Citation Analysis]
84 Naseri K, Dabiri H, Rostami-Nejad M, Yadegar A, Houri H, Olfatifar M, Sadeghi A, Saadati S, Ciacci C, Iovino P, Zali MR. Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. BMC Gastroenterol 2021;21:292. [PMID: 34261437 DOI: 10.1186/s12876-021-01868-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
85 Pejcz E, Lachowicz-Wiśniewska S, Nowicka P, Wojciechowicz-Budzisz A, Spychaj R, Gil Z. Effect of Inoculated Lactic Acid Fermentation on the Fermentable Saccharides and Polyols, Polyphenols and Antioxidant Activity Changes in Wheat Sourdough. Molecules 2021;26:4193. [PMID: 34299468 DOI: 10.3390/molecules26144193] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Schneider E, Sabate JM, Bouchoucha M, Debras C, Touvier M, Hercberg S, Benamouzig R, Buscail C, Julia C. FODMAP Consumption by Adults from the French Population-Based NutriNet-Santé Cohort. J Nutr 2021:nxab207. [PMID: 34224572 DOI: 10.1093/jn/nxab207] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Yan R, Murphy M, Genoni A, Marlow E, Dunican IC, Lo J, Andrew L, Devine A, Christophersen CT. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.BMJ Open Gastroenterol. 2020;7. [PMID: 32816830 DOI: 10.1136/bmjgast-2020-000448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Zhang Y, Feng L, Wang X, Fox M, Luo L, Du L, Chen B, Chen X, He H, Zhu S, Hu Z, Chen S, Long Y, Zhu Y, Xu L, Deng Y, Misselwitz B, Lang BM, Yilmaz B, Kim JJ, Owyang C, Dai N. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes.Am J Clin Nutr. 2021;. [PMID: 33740048 DOI: 10.1093/ajcn/nqab005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
89 Pérez de Arce E, Quera R, Quigley EMM. The Dilemma of Persistent Irritable Bowel Syndrome Symptoms in Patients with Quiescent Inflammatory Bowel Disease. Gastroenterol Clin North Am 2021;50:689-711. [PMID: 34304795 DOI: 10.1016/j.gtc.2021.03.008] [Reference Citation Analysis]
90 Singh P, Nee J. Role of Diet in Diarrhea-predominant Irritable Bowel Syndrome. J Clin Gastroenterol 2021;55:25-9. [PMID: 33060435 DOI: 10.1097/MCG.0000000000001445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
91 Yan R, Andrew L, Marlow E, Kunaratnam K, Devine A, Dunican IC, Christophersen CT. Dietary Fibre Intervention for Gut Microbiota, Sleep, and Mental Health in Adults with Irritable Bowel Syndrome: A Scoping Review. Nutrients 2021;13:2159. [PMID: 34201752 DOI: 10.3390/nu13072159] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
92 Simon E, Călinoiu LF, Mitrea L, Vodnar DC. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome. Nutrients 2021;13:2112. [PMID: 34203002 DOI: 10.3390/nu13062112] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
93 Di Chio T, Sokollik C, Peroni DG, Hart L, Simonetti G, Righini-Grunder F, Borrelli O. Nutritional Aspects of Pediatric Gastrointestinal Diseases. Nutrients 2021;13:2109. [PMID: 34205445 DOI: 10.3390/nu13062109] [Reference Citation Analysis]
94 Abreu Y Abreu AT, Milke-García MP, Argüello-Arévalo GA, Calderón-de la Barca AM, Carmona-Sánchez RI, Consuelo-Sánchez A, Coss-Adame E, García-Cedillo MF, Hernández-Rosiles V, Icaza-Chávez ME, Martínez-Medina JN, Morán-Ramos S, Ochoa-Ortiz E, Reyes-Apodaca M, Rivera-Flores RL, Zamarripa-Dorsey F, Zárate-Mondragón F, Vázquez-Frias R. Dietary fiber and the microbiota: A narrative review by a group of experts from the Asociación Mexicana de Gastroenterología. Rev Gastroenterol Mex (Engl Ed) 2021;86:287-304. [PMID: 34144942 DOI: 10.1016/j.rgmxen.2021.02.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Koochakpoor G, Salari-Moghaddam A, Keshteli AH, Esmaillzadeh A, Adibi P. Association of Coffee and Caffeine Intake With Irritable Bowel Syndrome in Adults. Front Nutr 2021;8:632469. [PMID: 34211993 DOI: 10.3389/fnut.2021.632469] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
96 Schindler V, Giezendanner S, Van Oudenhove L, Murray FR, Buehler J, Bordier V, Hente J, Pohl D. Better response to low FODMAP diet in disorders of gut-brain interaction patients with pronounced hydrogen response to a nutrient challenge test. J Gastroenterol Hepatol 2021. [PMID: 34107550 DOI: 10.1111/jgh.15573] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
97 Abreu Y Abreu AT, Milke-García MP, Argüello-Arévalo GA, Calderón-de la Barca AM, Carmona-Sánchez RI, Consuelo-Sánchez A, Coss-Adame E, García-Cedillo MF, Hernández-Rosiles V, Icaza-Chávez ME, Martínez-Medina JN, Morán-Ramos S, Ochoa-Ortiz E, Reyes-Apodaca M, Rivera-Flores RL, Zamarripa-Dorsey F, Zárate-Mondragón F, Vázquez-Frias R. Dietary fiber and the microbiota: A narrative review by a group of experts from the Asociación Mexicana de Gastroenterología. Rev Gastroenterol Mex 2021;86:287-304. [PMID: 34088566 DOI: 10.1016/j.rgmx.2021.02.004] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
98 Alfaro-Cruz L, Heitkemper M, Chumpitazi BP, Shulman RJ. Literature Review: Dietary Intervention Adherence and Adherence Barriers in Functional Gastrointestinal Disorder Studies. J Clin Gastroenterol 2020;54:203-11. [PMID: 31714332 DOI: 10.1097/MCG.0000000000001280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
99 Rej A, Shaw CC, Buckle RL, Trott N, Agrawal A, Mosey K, Sanders K, Allen R, Martin S, Newton A, Robinson K, Elphick D, Chey WD, Aziz I, Sanders DS. The low FODMAP diet for IBS; A multicentre UK study assessing long term follow up. Dig Liver Dis 2021:S1590-8658(21)00247-4. [PMID: 34083153 DOI: 10.1016/j.dld.2021.05.004] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
100 Rivière P, Vauquelin B, Rolland E, Melchior C, Roman S, Bruley des Varannes S, Mion F, Gourcerol G, Sacher-Huvelin S, Zerbib F. Low FODMAPs diet or usual dietary advice for the treatment of refractory gastroesophageal reflux disease: An open-labeled randomized trial. Neurogastroenterol Motil 2021;:e14181. [PMID: 34051134 DOI: 10.1111/nmo.14181] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
101 Kim MY, Choi SW. Dietary modulation of gut microbiota for the relief of irritable bowel syndrome. Nutr Res Pract 2021;15:411-30. [PMID: 34349876 DOI: 10.4162/nrp.2021.15.4.411] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
102 Johns J, Krogh K, Rodriguez GM, Eng J, Haller E, Heinen M, Laredo R, Longo W, Montero-Colon W, Wilson C, Korsten M. Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers. Top Spinal Cord Inj Rehabil 2021;27:75-151. [PMID: 34108835 DOI: 10.46292/sci2702-75] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
103 Gargano D, Appanna R, Santonicola A, De Bartolomeis F, Stellato C, Cianferoni A, Casolaro V, Iovino P. Food Allergy and Intolerance: A Narrative Review on Nutritional Concerns. Nutrients 2021;13:1638. [PMID: 34068047 DOI: 10.3390/nu13051638] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
104 Johns J, Krogh K, Rodriguez GM, Eng J, Haller E, Heinen M, Laredo R, Longo W, Montero-Colon W, Korsten M. Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury Suggested citation: Jeffery Johns, Klaus Krogh, Gianna M. Rodriguez, Janice Eng, Emily Haller, Malorie Heinen, Rafferty Laredo, Walter Longo, Wilda Montero-Colon, Mark Korsten. Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers. Journal of Spinal Cord Med. 2021. Doi:10.1080/10790268.2021.1883385. J Spinal Cord Med 2021;44:442-510. [PMID: 33905316 DOI: 10.1080/10790268.2021.1883385] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
105 Berumen A, Edwinson AL, Grover M. Post-infection Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:445-61. [PMID: 34024451 DOI: 10.1016/j.gtc.2021.02.007] [Reference Citation Analysis]
106 O'Brien L, Wall CL, Wilkinson TJ, Gearry RB. What Are the Pearls and Pitfalls of the Dietary Management for Chronic Diarrhoea? Nutrients 2021;13:1393. [PMID: 33919083 DOI: 10.3390/nu13051393] [Reference Citation Analysis]
107 Killian LA, Muir JG, Barrett JS, Burd NA, Lee SY. High Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Consumption Among Endurance Athletes and Relationship to Gastrointestinal Symptoms. Front Nutr 2021;8:637160. [PMID: 33959628 DOI: 10.3389/fnut.2021.637160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
108 Frieling T, Labenz J. [Functional gastrointestinal disorders are treated more efficiently by a multidisciplinary approach than standard gastroenterological care]. Z Gastroenterol 2021;59:360-3. [PMID: 33845501 DOI: 10.1055/a-1375-1587] [Reference Citation Analysis]
109 Benardout M, Le Gresley A, ElShaer A, Wren SP. Fructose malabsorption: causes, diagnosis and treatment. Br J Nutr 2021;:1-9. [PMID: 33818329 DOI: 10.1017/S0007114521001215] [Reference Citation Analysis]
110 Duncanson K, Burns G, Pryor J, Keely S, Talley NJ. Mechanisms of Food-Induced Symptom Induction and Dietary Management in Functional Dyspepsia. Nutrients 2021;13:1109. [PMID: 33800668 DOI: 10.3390/nu13041109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
111 Wellens J, Vermeire S, Sabino J. Let Food Be Thy Medicine-Its Role in Crohn's Disease. Nutrients 2021;13:832. [PMID: 33802429 DOI: 10.3390/nu13030832] [Reference Citation Analysis]
112 Jones J, Lembo A, Heidelbaugh J, Kuritzky L, Lacy B. Management of irritable bowel syndrome with diarrhea: focus on eluxadoline. Curr Med Res Opin 2021;37:567-78. [PMID: 33566707 DOI: 10.1080/03007995.2021.1888705] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
113 Rijnaarts I, Witteman BJM, Zoetendal EG, Govers C, de Wit NJW, de Roos NM. Subtypes and Severity of Irritable Bowel Syndrome Are Not Related to Patients' Self-Reported Dietary Triggers: Results From an Online Survey in Dutch Adults. J Acad Nutr Diet 2021;121:1750-1762.e8. [PMID: 33674208 DOI: 10.1016/j.jand.2021.01.007] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
114 Rej A, Sanders DS, Buckle RL, Trott N, Aziz I, Shaw CC. What is the optimal FODMAP threshold in IBS? J Gastroenterol Hepatol 2021;36:1723-5. [PMID: 33624857 DOI: 10.1111/jgh.15470] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
115 van Lanen AS, de Bree A, Greyling A. Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. Eur J Nutr 2021;60:3505-22. [PMID: 33585949 DOI: 10.1007/s00394-020-02473-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
116 Spiller R. Impact of Diet on Symptoms of the Irritable Bowel Syndrome. Nutrients 2021;13:575. [PMID: 33572262 DOI: 10.3390/nu13020575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
117 Goyal O, Batta S, Nohria S, Kishore H, Goyal P, Sehgal R, Sood A. Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial. J Gastroenterol Hepatol 2021;36:2107-15. [PMID: 33464683 DOI: 10.1111/jgh.15410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
118 Lacy BE, Cangemi D, Vazquez-roque M. Management of Chronic Abdominal Distension and Bloating. Clinical Gastroenterology and Hepatology 2021;19:219-231.e1. [DOI: 10.1016/j.cgh.2020.03.056] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 19.0] [Reference Citation Analysis]
119 Corsetti M, Brown S, Chiarioni G, Dimidi E, Dudding T, Emmanuel A, Fox M, Ford AC, Giordano P, Grossi U, Henderson M, Knowles CH, O'Connell PR, Quigley EMM, Simren M, Spiller R, Whelan K, Whitehead WE, Williams AB, Scott SM. Chronic constipation in adults: Contemporary perspectives and clinical challenges. 2: Conservative, behavioural, medical and surgical treatment. Neurogastroenterol Motil 2021;33:e14070. [PMID: 33522079 DOI: 10.1111/nmo.14070] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
120 Soltani S, Keshteli AH, Esmaillzadeh A, Adibi P. Adherence to Dietary Approaches to Stop Hypertension Eating Plan and Prevalence of Irritable Bowel Syndrome in Adults. J Neurogastroenterol Motil 2021;27:78-86. [PMID: 33380554 DOI: 10.5056/jnm20007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Onyimba F, Crowe SE, Johnson S, Leung J. Food Allergies and Intolerances: A Clinical Approach to the Diagnosis and Management of Adverse Reactions to Food. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00075-6. [PMID: 33493695 DOI: 10.1016/j.cgh.2021.01.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
122 Peppas S, Pansieri C, Piovani D, Danese S, Peyrin-Biroulet L, Tsantes AG, Brunetta E, Tsantes AE, Bonovas S. The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases. J Clin Med 2021;10:377. [PMID: 33498197 DOI: 10.3390/jcm10030377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
123 Joehnke MS, Jeske S, Ispiryan L, Zannini E, Arendt EK, Bez J, Sørensen JC, Petersen IL. Nutritional and anti-nutritional properties of lentil (Lens culinaris) protein isolates prepared by pilot-scale processing. Food Chem X 2021;9:100112. [PMID: 33851134 DOI: 10.1016/j.fochx.2020.100112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
124 Ao W, Cheng Y, Chen M, Wei F, Yang G, An Y, Mao F, Zhu X, Mao G. Intrinsic brain abnormalities of irritable bowel syndrome with diarrhea: a preliminary resting-state functional magnetic resonance imaging study. BMC Med Imaging 2021;21:4. [PMID: 33407222 DOI: 10.1186/s12880-020-00541-9] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
125 Scarlata K, Haller E. Nutrition Tools for the Practicing Gastroenterologist. Gastroenterol Clin North Am 2021;50:1-13. [PMID: 33518156 DOI: 10.1016/j.gtc.2020.10.011] [Reference Citation Analysis]
126 Holvoet T, Joossens M, Vázquez-castellanos JF, Christiaens E, Heyerick L, Boelens J, Verhasselt B, van Vlierberghe H, De Vos M, Raes J, De Looze D. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial. Gastroenterology 2021;160:145-157.e8. [DOI: 10.1053/j.gastro.2020.07.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
127 Harer KN, Eswaran SL. Irritable Bowel Syndrome: Food as a Friend or Foe? Gastroenterol Clin North Am 2021;50:183-99. [PMID: 33518164 DOI: 10.1016/j.gtc.2020.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
128 Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:17-44. [DOI: 10.14309/ajg.0000000000001036] [Cited by in Crossref: 47] [Cited by in F6Publishing: 103] [Article Influence: 23.5] [Reference Citation Analysis]
129 Rinninella E, Cintoni M, Raoul P, Gasbarrini A, Mele MC. Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track. Int J Environ Res Public Health. 2020;17:8816. [PMID: 33260947 DOI: 10.3390/ijerph17238816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
130 Grammatikopoulou MG, Goulis DG, Gkiouras K, Nigdelis MP, Papageorgiou ST, Papamitsou T, Forbes A, Bogdanos DP. Low FODMAP Diet for Functional Gastrointestinal Symptoms in Quiescent Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials. Nutrients 2020;12:E3648. [PMID: 33260902 DOI: 10.3390/nu12123648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
131 Suter DAI, Békés F. Who is to blame for the increasing prevalence of dietary sensitivity to wheat? CEREAL RESEARCH COMMUNICATIONS 2021;49:1-19. [DOI: 10.1007/s42976-020-00114-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Chiconato GC, Campos DJ, Thomaz AC, Moreira Funke VA, Vilela RM. Oral nutritional support to adult patients with acute intestinal Graft Versus Host Disease (GVHD): A proposal for dietary intervention as a model to clinical trials. Clin Nutr ESPEN 2020;40:369-75. [PMID: 33183565 DOI: 10.1016/j.clnesp.2020.07.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Dogan G, Yavuz S, Aslantas H, Ozyurt BC, Kasirga E. Is low FODMAP diet effective in children with irritable bowel syndrome? North Clin Istanb 2020;7:433-7. [PMID: 33163877 DOI: 10.14744/nci.2020.40326] [Reference Citation Analysis]
134 Thapar N, Benninga MA, Crowell MD, Di Lorenzo C, Mack I, Nurko S, Saps M, Shulman RJ, Szajewska H, van Tilburg MAL, Enck P. Paediatric functional abdominal pain disorders. Nat Rev Dis Primers 2020;6:89. [PMID: 33154368 DOI: 10.1038/s41572-020-00222-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
135 Aboubakr A, Cohen MS. Functional Bowel Disease. Clin Geriatr Med 2021;37:119-29. [PMID: 33213766 DOI: 10.1016/j.cger.2020.08.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
136 Sebastián Domingo J, Sánchez Sánchez C. La dieta baja en FODMAP, ¿es realmente eficaz y segura en el síndrome del intestino irritable?: una revisión panorámica. Medicina de Familia SEMERGEN 2020;46:566-76. [DOI: 10.1016/j.semerg.2020.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
137 Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. The Lancet 2020;396:1675-88. [DOI: 10.1016/s0140-6736(20)31548-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 122] [Article Influence: 21.0] [Reference Citation Analysis]
138 Fraberger V, Ladurner M, Nemec A, Grunwald-Gruber C, Call LM, Hochegger R, Domig KJ, D'Amico S. Insights into the Potential of Sourdough-Related Lactic Acid Bacteria to Degrade Proteins in Wheat. Microorganisms 2020;8:E1689. [PMID: 33143014 DOI: 10.3390/microorganisms8111689] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
139 Tuck CJ, De Palma G, Takami K, Brant B, Caminero A, Reed DE, Muir JG, Gibson PR, Winterborn A, Verdu EF, Bercik P, Vanner S. Nutritional profile of rodent diets impacts experimental reproducibility in microbiome preclinical research. Sci Rep 2020;10:17784. [PMID: 33082369 DOI: 10.1038/s41598-020-74460-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
140 Iacovou M, Gibson PR, Muir JG. Dietary Changes Among Breastfeeding Mothers. J Hum Lact 2021;37:566-76. [PMID: 33054509 DOI: 10.1177/0890334420959283] [Reference Citation Analysis]
141 Solomon S, Park E, Picoraro JA. Making Decisions about Dietary Therapy in Inflammatory Bowel Disease. GastrointestDisord 2020;2:353-65. [DOI: 10.3390/gidisord2040032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Krieger-Grübel C, Hutter S, Hiestand M, Brenner I, Güsewell S, Borovicka J. Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: A randomized, cross-over designed study. Clin Nutr ESPEN 2020;40:83-9. [PMID: 33183577 DOI: 10.1016/j.clnesp.2020.09.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
143 Basnayake C, Kamm MA, Stanley A, Wilson-o'brien A, Burrell K, Lees-trinca I, Khera A, Kantidakis J, Wong O, Fox K, Talley NJ, Liew D, Salzberg MR, Thompson AJ. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial. The Lancet Gastroenterology & Hepatology 2020;5:890-9. [DOI: 10.1016/s2468-1253(20)30215-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 18.5] [Reference Citation Analysis]
144 Liu Z, de Vries B, Gerritsen J, Smidt H, Zoetendal EG. Microbiome-based stratification to guide dietary interventions to improve human health. Nutrition Research 2020;82:1-10. [DOI: 10.1016/j.nutres.2020.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
145 O'Brien L, Skidmore P, Wall C, Wilkinson T, Muir J, Frampton C, Gearry R. A Low FODMAP Diet Is Nutritionally Adequate and Therapeutically Efficacious in Community Dwelling Older Adults with Chronic Diarrhoea. Nutrients 2020;12:E3002. [PMID: 33007886 DOI: 10.3390/nu12103002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
146 Demirkesen I, Ozkaya B. Recent strategies for tackling the problems in gluten-free diet and products. Critical Reviews in Food Science and Nutrition. [DOI: 10.1080/10408398.2020.1823814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
147 Axelrod CH, Saps M. Global Dietary Patterns and Functional Gastrointestinal Disorders. Children (Basel) 2020;7:E152. [PMID: 32992448 DOI: 10.3390/children7100152] [Reference Citation Analysis]
148 Wright-McNaughton M, Ten Bokkel Huinink S, Frampton CMA, McCombie AM, Talley NJ, Skidmore PML, Gearry RB. Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times Diary. Clin Transl Gastroenterol 2019;10:e00103. [PMID: 31800544 DOI: 10.14309/ctg.0000000000000103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
149 Uranga JA, Martínez V, Abalo R. Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use. Molecules 2020;25:E4314. [PMID: 32962285 DOI: 10.3390/molecules25184314] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
150 Liljebo T, Störsrud S, Andreasson A. Presence of Fermentable Oligo-, Di-, Monosaccharides, and Polyols (FODMAPs) in commonly eaten foods: extension of a database to indicate dietary FODMAP content and calculation of intake in the general population from food diary data. BMC Nutr 2020;6:47. [PMID: 32963797 DOI: 10.1186/s40795-020-00374-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
151 James SC, Fraser K, Young W, McNabb WC, Roy NC. Gut Microbial Metabolites and Biochemical Pathways Involved in Irritable Bowel Syndrome: Effects of Diet and Nutrition on the Microbiome. J Nutr 2020;150:1012-21. [PMID: 31891398 DOI: 10.1093/jn/nxz302] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
152 MendonÇa APM, Yamashita LM, Silva ED, Solar I, Santos LAO, Vasques ACJ. NUTRITIONAL STATUS, QUALITY OF LIFE AND LIFE HABITS OF WOMEN WITH IRRITABLE BOWEL SYNDROME: A CASE-CONTROL STUDY. Arq Gastroenterol 2020;57:114-20. [PMID: 32490902 DOI: 10.1590/s0004-2803.202000000-22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Gómez M, Gutkoski LC, Bravo‐núñez Á. Understanding whole‐wheat flour and its effect in breads: A review. Comprehensive Reviews in Food Science and Food Safety 2020;19:3241-65. [DOI: 10.1111/1541-4337.12625] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
154 Menees SB, Chandhrasekhar D, Liew EL, Chey WD. A Low FODMAP Diet May Reduce Symptoms in Patients With Fecal Incontinence. Clin Transl Gastroenterol 2019;10:e00060. [PMID: 31335356 DOI: 10.14309/ctg.0000000000000060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
155 Mahurkar-Joshi S, Chang L. Epigenetic Mechanisms in Irritable Bowel Syndrome. Front Psychiatry 2020;11:805. [PMID: 32922317 DOI: 10.3389/fpsyt.2020.00805] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
156 Ireton-Jones C, Weisberg MF. Management of Irritable Bowel Syndrome: Physician-Dietitian Collaboration. Nutr Clin Pract 2020;35:826-34. [PMID: 32786046 DOI: 10.1002/ncp.10567] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
157 Nakano K, Takahashi T, Tsunoda A, Shimizu Y. Effects of Dietary Guidance without Dietary Fiber Supplements on the Symptoms, Quality of Life, and Dietary Intake in Patients with Fecal Incontinence. J Anus Rectum Colon 2020;4:128-36. [PMID: 32743115 DOI: 10.23922/jarc.2020-008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
158 Li Q, Loponen J, Gänzle MG. Characterization of the Extracellular Fructanase FruA in Lactobacillus crispatus and Its Contribution to Fructan Hydrolysis in Breadmaking. J Agric Food Chem 2020;68:8637-47. [PMID: 32687341 DOI: 10.1021/acs.jafc.0c02313] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
159 Cheng P, Ma R, Wang S, Fang J, Zhong Z, Bai Y, Meng X, Li Z. Effect of the High-FODMAP Diet on Bowel Preparation for Colonoscopy: A Multicenter, Prospective Cohort Study. Gastroenterol Res Pract 2020;2020:1612040. [PMID: 32676102 DOI: 10.1155/2020/1612040] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
160 Fiers WD, Leonardi I, Iliev ID. From Birth and Throughout Life: Fungal Microbiota in Nutrition and Metabolic Health. Annu Rev Nutr 2020;40:323-43. [PMID: 32680437 DOI: 10.1146/annurev-nutr-013120-043659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
161 Weaver KN, Herfarth H. Gluten-Free Diet in IBD: Time for a Recommendation? Mol Nutr Food Res 2021;65:e1901274. [PMID: 32558265 DOI: 10.1002/mnfr.201901274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
162 Araya M, Bascuñán KA, Alarcón-Sajarópulos D, Cabrera-Chávez F, Oyarzún A, Fernández A, Ontiveros N. Living with Gluten and Other Food Intolerances: Self-Reported Diagnoses and Management. Nutrients 2020;12:E1892. [PMID: 32604710 DOI: 10.3390/nu12061892] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
163 Gibson PR, Halmos EP, Muir JG. Review article: FODMAPS, prebiotics and gut health-the FODMAP hypothesis revisited. Aliment Pharmacol Ther 2020;52:233-46. [PMID: 32562590 DOI: 10.1111/apt.15818] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
164 Lenders M, Boutin M, Auray-Blais C, Brand E. Effects of Orally Delivered Alpha-Galactosidase A on Gastrointestinal Symptoms in Patients With Fabry Disease. Gastroenterology 2020;159:1602-4. [PMID: 32534932 DOI: 10.1053/j.gastro.2020.06.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
165 Souza GN, Draghi PF, Yonamine GH. ORAL AND ENTERAL NUTRITION THERAPY IN INFLAMMATORY BOWEL DISEASES AMONG THE PEDIATRIC POPULATION: A LITERATURE REVIEW. Rev Paul Pediatr 2020;38:e2019032. [PMID: 32520298 DOI: 10.1590/1984-0462/2020/38/2019032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Kumral D, Syed S. Celiac Disease Screening for High-Risk Groups: Are We Doing It Right? Dig Dis Sci 2020;65:2187-95. [DOI: 10.1007/s10620-020-06352-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
167 Orlando A, Tutino V, Notarnicola M, Riezzo G, Linsalata M, Clemente C, Prospero L, Martulli M, D'Attoma B, De Nunzio V, Russo F. Improved Symptom Profiles and Minimal Inflammation in IBS-D Patients Undergoing a Long-Term Low-FODMAP Diet: A Lipidomic Perspective. Nutrients 2020;12:E1652. [PMID: 32498383 DOI: 10.3390/nu12061652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
168 Wilson B, Cox SR, Whelan K. Challenges of the low FODMAP diet for managing irritable bowel syndrome and approaches to their minimisation and mitigation. Proc Nutr Soc 2021;80:19-28. [PMID: 32468985 DOI: 10.1017/S0029665120006990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
169 Wilson B, Rossi M, Kanno T, Parkes GC, Anderson S, Mason AJ, Irving PM, Lomer MC, Whelan K. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria. Am J Gastroenterol 2020;115:906-15. [DOI: 10.14309/ajg.0000000000000641] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
170 Nyyssölä A, Ellilä S, Nordlund E, Poutanen K. Reduction of FODMAP content by bioprocessing. Trends in Food Science & Technology 2020;99:257-72. [DOI: 10.1016/j.tifs.2020.03.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
171 Talley NJ. What Causes Functional Gastrointestinal Disorders? A Proposed Disease Model. Am J Gastroenterol 2020;115:41-8. [PMID: 31895721 DOI: 10.14309/ajg.0000000000000485] [Cited by in Crossref: 22] [Cited by in F6Publishing: 37] [Article Influence: 11.0] [Reference Citation Analysis]
172 Novakovic M, Rout A, Kingsley T, Kirchoff R, Singh A, Verma V, Kant R, Chaudhary R. Role of gut microbiota in cardiovascular diseases. World J Cardiol 2020; 12(4): 110-122 [PMID: 32431782 DOI: 10.4330/wjc.v12.i4.110] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 21.0] [Reference Citation Analysis]
173 Weaver MJ, McHenry SA, Sayuk GS, Gyawali CP, Davidson NO. Bile Acid Diarrhea and NAFLD: Shared Pathways for Distinct Phenotypes. Hepatol Commun. 2020;4:493-503. [PMID: 32258945 DOI: 10.1002/hep4.1485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
174 Eswaran S, Dolan RD, Ball SC, Jackson K, Chey W. The Impact of a 4-Week Low-FODMAP and mNICE Diet on Nutrient Intake in a Sample of US Adults with Irritable Bowel Syndrome with Diarrhea. Journal of the Academy of Nutrition and Dietetics 2020;120:641-9. [DOI: 10.1016/j.jand.2019.03.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
175 Gravina AG, Dallio M, Romeo M, Di Somma A, Cotticelli G, Loguercio C, Federico A. Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation.Nutrients. 2020;12. [PMID: 32230832 DOI: 10.3390/nu12040928] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
176 Van den Houte K, Scarpellini E, Verbeure W, Mori H, Schol J, Masuy I, Carbone F, Tack J. The Role of GI Peptides in Functional Dyspepsia and Gastroparesis: A Systematic Review. Front Psychiatry 2020;11:172. [PMID: 32256403 DOI: 10.3389/fpsyt.2020.00172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
177 Barone M, Gemello E, Viggiani MT, Cristofori F, Renna C, Iannone A, Di Leo A, Francavilla R. Evaluation of Non-Celiac Gluten Sensitivity in Patients with Previous Diagnosis of Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial. Nutrients 2020;12:E705. [PMID: 32155878 DOI: 10.3390/nu12030705] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
178 Melchior C, Douard V, Coëffier M, Gourcerol G. Fructose and irritable bowel syndrome. Nutr Res Rev 2020;33:235-43. [PMID: 32122419 DOI: 10.1017/S0954422420000025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
179 Reker D, Blum SM, Steiger C, Anger KE, Sommer JM, Fanikos J, Traverso G. "Inactive" ingredients in oral medications. Sci Transl Med 2019;11:eaau6753. [PMID: 30867323 DOI: 10.1126/scitranslmed.aau6753] [Cited by in Crossref: 27] [Cited by in F6Publishing: 36] [Article Influence: 13.5] [Reference Citation Analysis]
180 Milajerdi A, Sadeghi O, Siadat SD, Keshavarz SA, Sima A, Vahedi H, Adibi P, Esmaillzadeh A. A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols on the intestinal microbiome and inflammation in patients with ulcerative colitis: study protocol for a randomized controlled trial. Trials 2020;21:201. [PMID: 32070388 DOI: 10.1186/s13063-020-4108-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
181 Pesce M, Cargiolli M, Cassarano S, Polese B, De Conno B, Aurino L, Mancino N, Sarnelli G. Diet and functional dyspepsia: Clinical correlates and therapeutic perspectives. World J Gastroenterol 2020; 26(5): 456-465 [PMID: 32089623 DOI: 10.3748/wjg.v26.i5.456] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
182 Holma R, Laatikainen R, Orell H, Joensuu H, Peuhkuri K, Poussa T, Korpela R, Österlund P. Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer. Nutrients 2020;12:E407. [PMID: 32033152 DOI: 10.3390/nu12020407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
183 Alfaro Cruz L, Minard C, Guffey D, Chumpitazi BP, Shulman RJ. Does a Minority of Children With Functional Gastrointestinal Disorders Receive Formal Diet Advice? JPEN J Parenter Enteral Nutr 2020;44:1525-9. [PMID: 32017170 DOI: 10.1002/jpen.1771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
184 Schaefer C, Zamboglou C, Volegova-Neher N, Martini C, Nicolay NH, Schmidt-Hegemann NS, Rogowski P, Li M, Belka C, Müller AC, Grosu AL, Brunner T. Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer - a prospective pilot study. Radiat Oncol 2020;15:27. [PMID: 32000818 DOI: 10.1186/s13014-020-1474-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
185 Cancarevic I, Rehman M, Iskander B, Lalani S, Malik BH. Is There a Correlation Between Irritable Bowel Syndrome and Lactose Intolerance? Cureus 2020;12:e6710. [PMID: 32104635 DOI: 10.7759/cureus.6710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
186 Daveson AJM, Tye-Din JA, Anderson RP. Editorial: inaccuracies in attribution of symptoms due to gluten-not just in those with self-reported noncoeliac gluten sensitivity. Authors' reply. Aliment Pharmacol Ther 2020;51:403-4. [PMID: 31943270 DOI: 10.1111/apt.15629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Hajishafiee M, Keshteli AH, Saneei P, Feinle-Bisset C, Esmaillzadeh A, Adibi P. Healthy lifestyle score and irritable bowel syndrome: A cross-sectional study in adults. Neurogastroenterol Motil 2020;32:e13793. [PMID: 31912611 DOI: 10.1111/nmo.13793] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
188 Bohlen L, Jeker R, Fehr T. CME: Hyperkalzämie. Praxis (Bern 1994) 2020;109:35-41. [PMID: 31910762 DOI: 10.1024/1661-8157/a003345] [Reference Citation Analysis]
189 Clevers E, Tran M, Van Oudenhove L, Störsrud S, Böhn L, Törnblom H, Simrén M. Adherence to diet low in fermentable carbohydrates and traditional diet for irritable bowel syndrome. Nutrition 2020;73:110719. [PMID: 32086111 DOI: 10.1016/j.nut.2020.110719] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
190 Bellini M, Tonarelli S, Nagy AG, Pancetti A, Costa F, Ricchiuti A, de Bortoli N, Mosca M, Marchi S, Rossi A. Low FODMAP Diet: Evidence, Doubts, and Hopes. Nutrients 2020;12:E148. [PMID: 31947991 DOI: 10.3390/nu12010148] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
191 Guerreiro MM, Santos Z, Carolino E, Correa J, Cravo M, Augusto F, Chagas C, Guerreiro CS. Effectiveness of Two Dietary Approaches on the Quality of Life and Gastrointestinal Symptoms of Individuals with Irritable Bowel Syndrome. J Clin Med 2020;9:E125. [PMID: 31906563 DOI: 10.3390/jcm9010125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
192 Cox SR, Lindsay JO, Fromentin S, Stagg AJ, Mccarthy NE, Galleron N, Ibraim SB, Roume H, Levenez F, Pons N, Maziers N, Lomer MC, Ehrlich SD, Irving PM, Whelan K. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. Gastroenterology 2020;158:176-188.e7. [DOI: 10.1053/j.gastro.2019.09.024] [Cited by in Crossref: 69] [Cited by in F6Publishing: 109] [Article Influence: 34.5] [Reference Citation Analysis]
193 Mitchell H, Porter J, Gibson PR, Barrett J, Garg M. Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research. Aliment Pharmacol Ther. 2019;49:124-139. [PMID: 30589971 DOI: 10.1111/apt.15079] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
194 Mack A, Bobardt JS, Haß A, Nichols KB, Schmid RM, Stein-Thoeringer CK. Changes in gut microbial metagenomic pathways associated with clinical outcomes after the elimination of malabsorbed sugars in an IBS cohort. Gut Microbes 2020;11:620-31. [PMID: 31809634 DOI: 10.1080/19490976.2019.1686322] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
195 Mehtab W, Agarwal A, Singh N, Malhotra A, Makharia GK. All that a physician should know about FODMAPs. Indian J Gastroenterol 2019;38:378-90. [PMID: 31802437 DOI: 10.1007/s12664-019-01002-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
196 Portincasa P, Lembo A, de Bari O, Di Palo DM, Maggio A, Cataldo I, Calamita G. The Role of Dietary Approach in Irritable Bowel Syndrome. Curr Med Chem 2019;26:3512-20. [PMID: 28462704 DOI: 10.2174/0929867324666170428102451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
197 Hambleton AL, Hanstock TL, Simeone R, Sperling M. Group-Delivered Enhanced Cognitive Behavior Therapy: A Focus on a Young Adult Woman With Bulimia Nervosa. Clinical Case Studies 2020;19:62-77. [DOI: 10.1177/1534650119886653] [Reference Citation Analysis]
198 Kamphuis JBJ, Guiard B, Leveque M, Olier M, Jouanin I, Yvon S, Tondereau V, Rivière P, Guéraud F, Chevolleau S, Noguer-Meireles MH, Martin JF, Debrauwer L, Eutamène H, Theodorou V. Lactose and Fructo-oligosaccharides Increase Visceral Sensitivity in Mice via Glycation Processes, Increasing Mast Cell Density in Colonic Mucosa. Gastroenterology 2020;158:652-663.e6. [PMID: 31711923 DOI: 10.1053/j.gastro.2019.10.037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
199 Appleton L, Day AS. Re: A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome. J Clin Med 2019;8:E1885. [PMID: 31698718 DOI: 10.3390/jcm8111885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
200 Hutson JM, Hynes MC, Kearsey I, Yik YI, Veysey DM, Tudball CF, Cain TM, King SK, Southwell BR. ‘Rapid transit’ constipation in children: a possible genesis for irritable bowel syndrome. Pediatr Surg Int 2020;36:11-9. [DOI: 10.1007/s00383-019-04587-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
201 Fagoonee S, Pellicano R. Does the Microbiota Play a Pivotal Role in the Pathogenesis of Irritable Bowel Syndrome? J Clin Med 2019;8:E1808. [PMID: 31671546 DOI: 10.3390/jcm8111808] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
202 Duncanson K, Burrows T, Keely S, Potter M, Das G, Walker M, Talley NJ. The Alignment of Dietary Intake and Symptom-Reporting Capture Periods in Studies Assessing Associations between Food and Functional Gastrointestinal Disorder Symptoms: A Systematic Review. Nutrients 2019;11:E2590. [PMID: 31661839 DOI: 10.3390/nu11112590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
203 Weynants A, Goossens L, Genetello M, De Looze D, Van Winckel M. The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome.J Hum Nutr Diet. 2020;33:159-169. [PMID: 31637777 DOI: 10.1111/jhn.12706] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
204 Geysen H, Gielis E, Deloose E, Vanuytsel T, Tack J, Biesiekierski JR, Pauwels A. Acute administration of fructans increases the number of transient lower esophageal sphincter relaxations in healthy volunteers. Neurogastroenterology & Motility 2019;32. [DOI: 10.1111/nmo.13727] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
205 Rinninella E, Cintoni M, Raoul P, Lopetuso LR, Scaldaferri F, Pulcini G, Miggiano GAD, Gasbarrini A, Mele MC. Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. Nutrients 2019;11:E2393. [PMID: 31591348 DOI: 10.3390/nu11102393] [Cited by in Crossref: 111] [Cited by in F6Publishing: 151] [Article Influence: 37.0] [Reference Citation Analysis]
206 Defaye M, Gervason S, Altier C, Berthon JY, Ardid D, Filaire E, Carvalho FA. Microbiota: a novel regulator of pain. J Neural Transm (Vienna) 2020;127:445-65. [PMID: 31552496 DOI: 10.1007/s00702-019-02083-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
207 Kalantar-Zadeh K, Berean KJ, Burgell RE, Muir JG, Gibson PR. Intestinal gases: influence on gut disorders and the role of dietary manipulations. Nat Rev Gastroenterol Hepatol 2019;16:733-47. [PMID: 31520080 DOI: 10.1038/s41575-019-0193-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 18.3] [Reference Citation Analysis]
208 Algera J, Colomier E, Simrén M. The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence. Nutrients 2019;11:E2162. [PMID: 31505870 DOI: 10.3390/nu11092162] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
209 Chumpitazi BP, Alfaro-Cruz L, Zia JK, Shulman RJ, Heitkemper MM. Commentary: Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? Front Nutr 2019;6:136. [PMID: 31552257 DOI: 10.3389/fnut.2019.00136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
210 Kim SE. Importance of nutritional therapy in the management of intestinal diseases: beyond energy and nutrient supply. Intest Res 2019;17:443-54. [PMID: 31474088 DOI: 10.5217/ir.2019.00075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
211 Tye-Din JA, Daveson AJM, Ee HC, Goel G, MacDougall J, Acaster S, Goldstein KE, Dzuris JL, Neff KM, Truitt KE, Anderson RP. Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease. Aliment Pharmacol Ther 2019;50:901-10. [PMID: 31483515 DOI: 10.1111/apt.15477] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
212 Tye-Din JA, Skodje GI, Sarna VK, Dzuris JL, Russell AK, Goel G, Wang S, Goldstein KE, Williams LJ, Sollid LM, Lundin KE, Anderson RP. Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity. United European Gastroenterol J 2020;8:108-18. [PMID: 32213060 DOI: 10.1177/2050640619874173] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
213 Linlawan S, Patcharatrakul T, Somlaw N, Gonlachanvit S. Effect of Rice, Wheat, and Mung Bean Ingestion on Intestinal Gas Production and Postprandial Gastrointestinal Symptoms in Non-Constipation Irritable Bowel Syndrome Patients. Nutrients. 2019;11:2061. [PMID: 31484315 DOI: 10.3390/nu11092061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
214 Basnayake C, Kamm MA, Salzberg MR, Wilson‐o'brien A, Stanley A, Thompson AJ. Delivery of care for functional gastrointestinal disorders: A systematic review. Journal of Gastroenterology and Hepatology 2019;35:204-10. [DOI: 10.1111/jgh.14830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
215 Jouët P, Morel N. Régime pauvre en FODMAPS, ce que doivent savoir les nutritionnistes. Nutrition Clinique et Métabolisme 2019;33:199-204. [DOI: 10.1016/j.nupar.2019.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
216 Carter T, Goldenberg JZ, Steel A. An examination of naturopathic treatment of non-specific gastrointestinal complaints: comparative analysis of two cases. Integr Med Res 2019;8:209-15. [PMID: 31467841 DOI: 10.1016/j.imr.2019.08.001] [Reference Citation Analysis]
217 Rej A, Aziz I, Tornblom H, Sanders DS, Simrén M. The role of diet in irritable bowel syndrome: implications for dietary advice. J Intern Med 2019;286:490-502. [DOI: 10.1111/joim.12966] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
218 Dieterich W, Zopf Y. Gluten and FODMAPS-Sense of a Restriction/When Is Restriction Necessary? Nutrients 2019;11:E1957. [PMID: 31434299 DOI: 10.3390/nu11081957] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
219 Basnayake C, Kamm MA, Salzberg M, Khera A, Liew D, Burrell K, Wilson-O'Brien A, Stanley A, Talley NJ, Thompson AJ. Defining Optimal Care for Functional Gut Disorders - Multi-Disciplinary Versus Standard Care: A Randomized Controlled Trial Protocol. Contemp Clin Trials 2019;84:105828. [PMID: 31437539 DOI: 10.1016/j.cct.2019.105828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
220 Scarlata K, Catsos P, Smith J. From a Dietitian's Perspective, Diets for Irritable Bowel Syndrome Are Not One Size Fits All. Clin Gastroenterol Hepatol 2020;18:543-5. [PMID: 31437487 DOI: 10.1016/j.cgh.2019.08.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
221 Ibrahim F, Stribling P. A 5Ad Dietary Protocol for Functional Bowel Disorders. Nutrients 2019;11:E1938. [PMID: 31426496 DOI: 10.3390/nu11081938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
222 Galli V, Venturi M, Pini N, Guerrini S, Granchi L. Exploitation of sourdough lactic acid bacteria to reduce raffinose family oligosaccharides (RFOs) content in breads enriched with chickpea flour. Eur Food Res Technol 2019;245:2353-63. [DOI: 10.1007/s00217-019-03353-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
223 Ford AC, Moayyedi P, Chey WD, Harris LA, Lacy BE, Saito YA, Quigley EMM; ACG Task Force on Management of Irritable Bowel Syndrome. American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2018;113:1-18. [PMID: 29950604 DOI: 10.1038/s41395-018-0084-x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 151] [Article Influence: 46.7] [Reference Citation Analysis]
224 McKinney P, Cox AM, Sbaffi L. Information Literacy in Food and Activity Tracking Among Parkrunners, People With Type 2 Diabetes, and People With Irritable Bowel Syndrome: Exploratory Study. J Med Internet Res 2019;21:e13652. [PMID: 31373277 DOI: 10.2196/13652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
225 Tuck CJ, Biesiekierski JR, Schmid-Grendelmeier P, Pohl D. Food Intolerances. Nutrients 2019;11:E1684. [PMID: 31336652 DOI: 10.3390/nu11071684] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
226 Simrén M, Tack J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol 2018;15:589-605. [PMID: 29930260 DOI: 10.1038/s41575-018-0034-5] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 25.3] [Reference Citation Analysis]
227 Wang XJ, Camilleri M, Vanner S, Tuck C. Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction. Aliment Pharmacol Ther 2019;50:517-29. [DOI: 10.1111/apt.15419] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
228 Paduano D, Cingolani A, Tanda E, Usai P. Effect of Three Diets (Low-FODMAP, Gluten-free and Balanced) on Irritable Bowel Syndrome Symptoms and Health-Related Quality of Life.Nutrients. 2019;11. [PMID: 31336747 DOI: 10.3390/nu11071566] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
229 Tuck CJ, Caminero A, Jiménez Vargas NN, Soltys CL, Jaramillo Polanco JO, Lopez Lopez CD, Constante M, Lourenssen SR, Verdu EF, Muir JG, Lomax AE, Reed DE, Vanner SJ. The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome. Neurogastroenterol Motil 2019;31:e13675. [PMID: 31290223 DOI: 10.1111/nmo.13675] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
230 Gwee KA, Gonlachanvit S, Ghoshal UC, Chua ASB, Miwa H, Wu J, Bak YT, Lee OY, Lu CL, Park H, Chen M, Syam AF, Abraham P, Sollano J, Chang CS, Suzuki H, Fang X, Fukudo S, Choi MG, Hou X, Hongo M. Second Asian Consensus on Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2019;25:343-362. [PMID: 31327218 DOI: 10.5056/jnm19041] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
231 Rice T, Zannini E, K Arendt E, Coffey A. A review of polyols - biotechnological production, food applications, regulation, labeling and health effects. Crit Rev Food Sci Nutr 2020;60:2034-51. [PMID: 31210053 DOI: 10.1080/10408398.2019.1625859] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
232 Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy. Front Microbiol. 2019;10:1136. [PMID: 31244784 DOI: 10.3389/fmicb.2019.01136] [Cited by in Crossref: 60] [Cited by in F6Publishing: 85] [Article Influence: 20.0] [Reference Citation Analysis]
233 Choung RS, Murray JA. The Role for Food Allergies in the Pathogenesis of Irritable Bowel Syndrome: Understanding Mechanisms of Intestinal Mucosal Responses Against Food Antigens. Gastroenterology 2019;157:15-7. [PMID: 31145873 DOI: 10.1053/j.gastro.2019.05.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
234 Camilleri M. Management Options for Irritable Bowel Syndrome. Mayo Clin Proc. 2018;93:1858-1872. [PMID: 30522596 DOI: 10.1016/j.mayocp.2018.04.032] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
235 Spiller R, Marciani L. Intraluminal Impact of Food: New Insights from MRI. Nutrients 2019;11:E1147. [PMID: 31126027 DOI: 10.3390/nu11051147] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
236 Yamamoto M, Pinto-Sanchez MI, Bercik P, Britz-McKibbin P. Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients. Metabolomics 2019;15:82. [PMID: 31111238 DOI: 10.1007/s11306-019-1543-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
237 Lopes SS, Miszputen SJ, Sachs A, Lima MM, Ambrogini O. Evaluation of carbohydrate and fiber consumption in patients with irritable bowel syndrome in outpatient treatment. Arq Gastroenterol. 2019;56:3-9. [PMID: 31141064 DOI: 10.1590/s0004-2803.201900000-12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
238 Zhang JJ, Ma H, Zhu JZ, Lu C, Yu CH, Li YM. The Role of Dietary Energy and Macronutrients Intake in Prevalence of Irritable Bowel Syndromes. Biomed Res Int 2019;2019:8967306. [PMID: 31223623 DOI: 10.1155/2019/8967306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
239 Fritscher-Ravens A, Pflaum T, Mösinger M, Ruchay Z, Röcken C, Milla PJ, Das M, Böttner M, Wedel T, Schuppan D. Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin E. Gastroenterology 2019;157:109-118.e5. [PMID: 31100380 DOI: 10.1053/j.gastro.2019.03.046] [Cited by in Crossref: 61] [Cited by in F6Publishing: 87] [Article Influence: 20.3] [Reference Citation Analysis]
240 Okawa Y, Fukudo S, Sanada H. Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: a review. Biopsychosoc Med. 2019;13:10. [PMID: 31080496 DOI: 10.1186/s13030-019-0152-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
241 Killian LA, Lee SY. Irritable bowel syndrome is underdiagnosed and ineffectively managed among endurance athletes. Appl Physiol Nutr Metab 2019;44:1329-38. [PMID: 31063696 DOI: 10.1139/apnm-2019-0261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
242 Costa RJS, Gaskell SK, McCubbin AJ, Snipe RMJ. Exertional-heat stress-associated gastrointestinal perturbations during Olympic sports: Management strategies for athletes preparing and competing in the 2020 Tokyo Olympic Games. Temperature (Austin) 2020;7:58-88. [PMID: 32166105 DOI: 10.1080/23328940.2019.1597676] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
243 Mari A, Abu Backer F, Mahamid M, Amara H, Carter D, Boltin D, Dickman R. Bloating and Abdominal Distension: Clinical Approach and Management. Adv Ther 2019;36:1075-84. [PMID: 30879252 DOI: 10.1007/s12325-019-00924-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
244 Lee HJ, Kim HJ, Kang EH, Jung KW, Myung SJ, Min YW, Choi CH, Ryu HS, Choi JK, Kwon JG, Hong KS, Park KS. Self-reported Food Intolerance in Korean Patients With Irritable Bowel Syndrome. J Neurogastroenterol Motil 2019;25:222-32. [PMID: 30827068 DOI: 10.5056/jnm18125] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
245 Mari A, Hosadurg D, Martin L, Zarate-Lopez N, Passananti V, Emmanuel A. Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? Eur J Gastroenterol Hepatol. 2019;31:178-182. [PMID: 30543574 DOI: 10.1097/meg.0000000000001317] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
246 Ispiryan L, Heitmann M, Hoehnel A, Zannini E, Arendt EK. Optimization and Validation of an HPAEC-PAD Method for the Quantification of FODMAPs in Cereals and Cereal-Based Products. J Agric Food Chem 2019;67:4384-92. [PMID: 30915837 DOI: 10.1021/acs.jafc.9b00382] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
247 Halmos EP, Gibson PR. Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome.J Gastroenterol Hepatol. 2019;34:1134-1142. [PMID: 30945376 DOI: 10.1111/jgh.14650] [Cited by in Crossref: 31] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
248 Gentile CL, Weir TL. The gut microbiota at the intersection of diet and human health. Science. 2018;362:776-780. [PMID: 30442802 DOI: 10.1126/science.aau5812] [Cited by in Crossref: 294] [Cited by in F6Publishing: 366] [Article Influence: 98.0] [Reference Citation Analysis]
249 Labus JS, Osadchiy V, Hsiao EY, Tap J, Derrien M, Gupta A, Tillisch K, Le Nevé B, Grinsvall C, Ljungberg M, Öhman L, Törnblom H, Simren M, Mayer EA. Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis. Microbiome 2019;7:45. [PMID: 30898151 DOI: 10.1186/s40168-019-0656-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 54] [Article Influence: 12.3] [Reference Citation Analysis]
250 Baranguán Castro ML, Ros Arnal I, García Romero R, Rodríguez Martínez G, Ubalde Sainz E. Implementation of a low FODMAP diet for functional abdominal pain. Anales de Pediatría (English Edition) 2019;90:180-6. [DOI: 10.1016/j.anpede.2018.02.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
251 Vasant DH, Whorwell PJ. Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol. Neurogastroenterol Motil. 2019;31:e13573. [PMID: 30815936 DOI: 10.1111/nmo.13573] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
252 Fragkos KC, Keetarut K, Cox A, Eady J, Emmanuel AV, Zarate-Lopez N. Joint Hypermobility Syndrome Affects Response to a Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide and Polyol Diet in Irritable Bowel Syndrome Patients: A Retrospective Study. Gastroenterology Res 2019;12:27-36. [PMID: 30834032 DOI: 10.14740/gr1133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
253 Rossi M, Casale G, Badiali D, Aielli F, Aloe Spiriti MA, Arcioni R, Bordin F, Ferrara M, Morelli Sbarra G, Corcione A, Marinangeli F, Marchetti P. Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert Board. Support Care Cancer 2019;27:4083-90. [PMID: 30778756 DOI: 10.1007/s00520-019-04688-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
254 Basnayake C, Kamm MA, Salzberg M, Stanley A, Khera A, Burrell K, Wilson-o’brien A, Hebbard G, Thompson AJ. Outcome of hospital outpatient treatment of functional gastrointestinal disorders: Functional gastrointestinal disorders. Intern Med J 2019;49:225-31. [DOI: 10.1111/imj.14067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
255 Muir JG, Iacovou M. Editorial: irritable bowel syndrome-in addition to having properly-trained dietitians, is it time to add a yoga teacher to our multidisciplinary team? Aliment Pharmacol Ther 2018;47:432-3. [PMID: 29314137 DOI: 10.1111/apt.14448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
256 Saito YA, Almazar AE, Tilkes KE, Choung RS, Van Norstrand MD, Schleck CD, Zinsmeister AR, Talley NJ. Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome. Aliment Pharmacol Ther 2019;49:389-97. [PMID: 30663077 DOI: 10.1111/apt.15077] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 10.7] [Reference Citation Analysis]
257 Hitschfeld M, Tovar E, Gupta S, Bik EM, Palmer C, Hoaglin MC, Almonacid DE, Richman J, Apte ZS. The role of a sequencing-based clinical intestinal screening test in patients at high-risk for Clostridium difficile and other pathogens: a case report. J Med Case Rep 2019;13:9. [PMID: 30642394 DOI: 10.1186/s13256-018-1919-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
258 Madzhidova S, Sedrakyan L. The Use of Dietary Interventions in Pediatric Patients. Pharmacy (Basel) 2019;7:E10. [PMID: 30650554 DOI: 10.3390/pharmacy7010010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
259 Wiffin M, Smith L, Antonio J, Johnstone J, Beasley L, Roberts J. Effect of a short-term low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet on exercise-related gastrointestinal symptoms. J Int Soc Sports Nutr 2019;16:1. [PMID: 30646926 DOI: 10.1186/s12970-019-0268-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
260 Kim JH, Jee SR. Irritable Bowel Syndrome. Korean J Gastroenterol 2019;73:84. [DOI: 10.4166/kjg.2019.73.2.84] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
261 Pauls RN, Max JB. Symptoms and dietary practices of irritable bowel syndrome patients compared to controls: results of a USA national survey. Minerva Gastroenterol Dietol 2019;65. [DOI: 10.23736/s1121-421x.18.02518-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
262 Zhang Y, Ma ZF, Zhang H, Pan B, Li Y, Majid HA, Lee YY. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polypols diet and irritable bowel syndrome in Asia. JGH Open 2019;3:173-8. [PMID: 31061894 DOI: 10.1002/jgh3.12125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
263 Pietrzak A, Skrzydło-Radomańska B, Mulak A, Lipiński M, Małecka-Panas E, Reguła J, Rydzewska G. Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik. Prz Gastroenterol 2018;13:259-88. [PMID: 30581501 DOI: 10.5114/pg.2018.78343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
264 Van den Houte K, Carbone F, Pannemans J, Corsetti M, Fischler B, Piessevaux H, Tack J. Prevalence and impact of self-reported irritable bowel symptoms in the general population. United European Gastroenterol J 2019;7:307-15. [PMID: 31080615 DOI: 10.1177/2050640618821804] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
265 Volta U, De Giorgio R, Caio G, Uhde M, Manfredini R, Alaedini A. Nonceliac Wheat Sensitivity: An Immune-Mediated Condition with Systemic Manifestations. Gastroenterol Clin North Am 2019;48:165-82. [PMID: 30711208 DOI: 10.1016/j.gtc.2018.09.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
266 O'Malley D. Endocrine regulation of gut function - a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome. Exp Physiol 2019;104:3-10. [PMID: 30444291 DOI: 10.1113/EP087443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
267 Mezzomo TR, Sampaio IR, Fiori LS, Schieferdecker MEM. Content of Poorly Absorbed Short-Chain Carbohydrates (FODMAP) in Enteral Homemade Diets. Nutrition in Clinical Practice 2019;34:264-71. [DOI: 10.1002/ncp.10223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
268 Graziano M, Rossi M. An update on the cutaneous manifestations of coeliac disease and non-coeliac gluten sensitivity. Int Rev Immunol. 2018;37:291-300. [PMID: 30516407 DOI: 10.1080/08830185.2018.1533008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
269 Manning LP, Biesiekierski JR. Use of dietary interventions for functional gastrointestinal disorders. Current Opinion in Pharmacology 2018;43:132-8. [DOI: 10.1016/j.coph.2018.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
270 Grace S, Barnes L, Reilly W, Vlass A, de Permentier P. An integrative review of dietetic and naturopathic approaches to functional bowel disorders. Complement Ther Med 2018;41:67-80. [PMID: 30477867 DOI: 10.1016/j.ctim.2018.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
271 McMeans AR, King KL, Chumpitazi BP. Low FODMAP Dietary Food Lists are Often Discordant. Am J Gastroenterol. 2017;112:655-656. [PMID: 28381835 DOI: 10.1038/ajg.2016.593] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
272 Roncoroni L, Elli L, Doneda L, Bascuñán KA, Vecchi M, Morreale F, Scricciolo A, Lombardo V, Pellegrini N. A Retrospective Study on Dietary FODMAP Intake in Celiac Patients Following a Gluten-Free Diet. Nutrients 2018;10:E1769. [PMID: 30445688 DOI: 10.3390/nu10111769] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
273 Fifi AC, Axelrod CH, Chakraborty P, Saps M. Herbs and Spices in the Treatment of Functional Gastrointestinal Disorders: A Review of Clinical Trials. Nutrients 2018;10:E1715. [PMID: 30423929 DOI: 10.3390/nu10111715] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
274 Rawla P, Sunkara T, Raj JP. Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome. Life Sciences 2018;212:176-81. [DOI: 10.1016/j.lfs.2018.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
275 Singh R, Salem A, Nanavati J, Mullin GE. The Role of Diet in the Treatment of Irritable Bowel Syndrome: A Systematic Review. Gastroenterol Clin North Am 2018;47:107-37. [PMID: 29413008 DOI: 10.1016/j.gtc.2017.10.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
276 Muir JG, Varney JE, Ajamian M, Gibson PR. Gluten-free and low-FODMAP sourdoughs for patients with coeliac disease and irritable bowel syndrome: A clinical perspective. Int J Food Microbiol 2019;290:237-46. [PMID: 30388591 DOI: 10.1016/j.ijfoodmicro.2018.10.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
277 Rej A, Aziz I, Sanders DS. Breaking bread! Proc Nutr Soc 2019;78:118-25. [DOI: 10.1017/s0029665118002549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
278 Basnayake C. Treatment of irritable bowel syndrome. Aust Prescr 2018;41:145-9. [PMID: 30410210 DOI: 10.18773/austprescr.2018.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
279 Chumpitazi BP. Update on Dietary Management of Childhood Functional Abdominal Pain Disorders. Gastroenterol Clin North Am 2018;47:715-26. [PMID: 30337028 DOI: 10.1016/j.gtc.2018.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
280 Khlevner J, Park Y, Margolis KG. Brain-Gut Axis: Clinical Implications. Gastroenterol Clin North Am 2018;47:727-39. [PMID: 30337029 DOI: 10.1016/j.gtc.2018.07.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
281 Adriani A, Ribaldone DG, Astegiano M, Durazzo M, Saracco GM, Pellicano R. Irritable bowel syndrome: the clinical approach. Panminerva Med. 2018;60:213-222. [PMID: 30257542 DOI: 10.23736/s0031-0808.18.03541-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
282 McDonald E, Teets R, Ortiz C, Gilchrist C, Waltermaurer E, Perez E, Kligler B. A Randomized Trial of a Group-Based Integrative Medicine Approach Compared to Waitlist Control on Irritable Bowel Syndrome Symptoms in Adults. Explore (NY) 2018;14:406-13. [PMID: 30243949 DOI: 10.1016/j.explore.2018.04.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
283 Gargari G, Taverniti V, Gardana C, Cremon C, Canducci F, Pagano I, Barbaro MR, Bellacosa L, Castellazzi AM, Valsecchi C, Tagliacarne SC, Bellini M, Bertani L, Gambaccini D, Marchi S, Cicala M, Germanà B, Dal Pont E, Vecchi M, Ogliari C, Fiore W, Stanghellini V, Barbara G, Guglielmetti S. Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome. Environ Microbiol 2018;20:3201-13. [PMID: 29749705 DOI: 10.1111/1462-2920.14271] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
284 Staudacher HM, Tuck CJ. Applying precision to the design and interpretation of dietary trials. Clin Nutr 2018;37:2291. [PMID: 30227986 DOI: 10.1016/j.clnu.2018.08.020] [Reference Citation Analysis]
285 Mearin F, Rey E, Santander C. Irritable bowel syndrome: How to improve decision making in clinical practice. Med Clin (Barc) 2018;151:489-97. [PMID: 30243429 DOI: 10.1016/j.medcli.2018.06.020] [Reference Citation Analysis]
286 Zhou C, Zhao E, Li Y, Jia Y, Li F. Exercise therapy of patients with irritable bowel syndrome: A systematic review of randomized controlled trials. Neurogastroenterol Motil 2019;31:e13461. [PMID: 30232834 DOI: 10.1111/nmo.13461] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
287 Killian LA, Chapman-Novakofski KM, Lee SY. Questionnaire on Irritable Bowel Syndrome and Symptom Management Among Endurance Athletes Is Valid and Reliable. Dig Dis Sci 2018;63:3281-9. [PMID: 30232638 DOI: 10.1007/s10620-018-5289-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
288 Thirunathan P, Manickavasagan A. Processing methods for reducing alpha-galactosides in pulses. Critical Reviews in Food Science and Nutrition 2019;59:3334-48. [DOI: 10.1080/10408398.2018.1490886] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
289 Ihekweazu FD, Versalovic J. Development of the Pediatric Gut Microbiome: Impact on Health and Disease. Am J Med Sci 2018;356:413-23. [PMID: 30384950 DOI: 10.1016/j.amjms.2018.08.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
290 Vulevic J, Tzortzis G, Juric A, Gibson GR. Effect of a prebiotic galactooligosaccharide mixture (B-GOS®) on gastrointestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence. Neurogastroenterol Motil 2018;30:e13440. [DOI: 10.1111/nmo.13440] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
291 Waingankar K, Lai C, Punwani V, Wong J, Hutson JM, Southwell BR. Dietary exclusion of fructose and lactose after positive breath tests improved rapid-transit constipation in children. JGH Open 2018;2:262-9. [PMID: 30619935 DOI: 10.1002/jgh3.12079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
292 Graham DY, Ketwaroo GA, Money ME, Opekun AR. Enzyme therapy for functional bowel disease-like post-prandial distress. J Dig Dis 2018;19:650-6. [PMID: 30101562 DOI: 10.1111/1751-2980.12655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
293 Roncoroni L, Bascuñán KA, Doneda L, Scricciolo A, Lombardo V, Branchi F, Ferretti F, Dell'Osso B, Montanari V, Bardella MT, Elli L. A Low FODMAP Gluten-Free Diet Improves Functional Gastrointestinal Disorders and Overall Mental Health of Celiac Disease Patients: A Randomized Controlled Trial. Nutrients 2018;10:E1023. [PMID: 30081576 DOI: 10.3390/nu10081023] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
294 Arasaradnam RP, Brown S, Forbes A, Fox MR, Hungin P, Kelman L, Major G, O'Connor M, Sanders DS, Sinha R, Smith SC, Thomas P, Walters JRF. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut 2018;67:1380-99. [PMID: 29653941 DOI: 10.1136/gutjnl-2017-315909] [Cited by in Crossref: 126] [Cited by in F6Publishing: 110] [Article Influence: 31.5] [Reference Citation Analysis]
295 Giron F, Quigley EMM. Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective. J Neurogastroenterol Motil 2018;24:355-66. [PMID: 29684976 DOI: 10.5056/jnm18004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
296 Lenhart A, Ferch C, Shaw M, Chey WD. Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of Over 1500 United States Gastroenterologists. J Neurogastroenterol Motil 2018;24:437-51. [PMID: 29886578 DOI: 10.5056/jnm17116] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
297 Cox SR, Prince AC, Myers CE, Irving PM, Lindsay JO, Lomer MC, Whelan K. Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial. J Crohns Colitis. 2017;11:1420-1429. [PMID: 28525543 DOI: 10.1093/ecco-jcc/jjx073] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 13.8] [Reference Citation Analysis]
298 Dionne J, Ford AC, Yuan Y, Chey WD, Lacy BE, Saito YA, Quigley EMM, Moayyedi P. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. Am J Gastroenterol. 2018;113:1290-1300. [PMID: 30046155 DOI: 10.1038/s41395-018-0195-4] [Cited by in Crossref: 106] [Cited by in F6Publishing: 119] [Article Influence: 26.5] [Reference Citation Analysis]
299 Koci O, Logan M, Svolos V, Russell RK, Gerasimidis K, Ijaz UZ. An automated identification and analysis of ontological terms in gastrointestinal diseases and nutrition-related literature provides useful insights. PeerJ 2018;6:e5047. [PMID: 30065857 DOI: 10.7717/peerj.5047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
300 Caballero N, Marin I, Serra J. Gastric gas dynamics in healthy humans. Neurogastroenterol Motil 2018;30:e13408. [PMID: 30043526 DOI: 10.1111/nmo.13408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
301 Polese B, Nicolai E, Genovese D, Verlezza V, La Sala CN, Aiello M, Inglese M, Incoronato M, Sarnelli G, De Rosa T, Schiatti A, Mondelli F, Ercolini D, Cuomo R. Postprandial Gastrointestinal Function Differs after Acute Administration of Sourdough Compared with Brewer's Yeast Bakery Products in Healthy Adults. J Nutr 2018;148:202-8. [PMID: 29490103 DOI: 10.1093/jn/nxx049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
302 Sloan TJ, Jalanka J, Major GAD, Krishnasamy S, Pritchard S, Abdelrazig S, Korpela K, Singh G, Mulvenna C, Hoad CL, Marciani L, Barrett DA, Lomer MCE, de Vos WM, Gowland PA, Spiller RC. A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects. PLoS One 2018;13:e0201410. [PMID: 30048547 DOI: 10.1371/journal.pone.0201410] [Cited by in Crossref: 40] [Cited by in F6Publishing: 48] [Article Influence: 10.0] [Reference Citation Analysis]
303 Spiller R. Inhibiting glucose absorption to treat constipation. Lancet Gastroenterol Hepatol 2018;3:588-9. [PMID: 30056027 DOI: 10.1016/S2468-1253(18)30214-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
304 Frech TM, Mar D. Gastrointestinal and Hepatic Disease in Systemic Sclerosis. Rheum Dis Clin North Am. 2018;44:15-28. [PMID: 29149923 DOI: 10.1016/j.rdc.2017.09.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
305 Jalanka J, Spiller R. Role of microbiota in the pathogenesis of functional disorders of the lower GI tract: Work in progress. Neurogastroenterol Motil 2017;29:1-5. [PMID: 28891277 DOI: 10.1111/nmo.13194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
306 Massironi S, Branchi F, Fraquelli M, Baccarin A, Somalvico F, Ferretti F, Conte D, Elli L. Effects of a Gluten-Containing Meal on Gastric Emptying and Gallbladder Contraction. Nutrients 2018;10:E910. [PMID: 30012987 DOI: 10.3390/nu10070910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
307 Dale HF, Biesiekierski JR, Lied GA. Non-coeliac gluten sensitivity and the spectrum of gluten-related disorders: an updated overview. Nutr Res Rev 2019;32:28-37. [PMID: 30009718 DOI: 10.1017/S095442241800015X] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
308 Gwee KA, Ghoshal UC, Chen M. Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management. J Gastroenterol Hepatol 2018;33:99-110. [PMID: 28901578 DOI: 10.1111/jgh.13987] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
309 Wong Z, Mok CZ, Majid HA, Mahadeva S. Early experience with a low FODMAP diet in Asian patients with irritable bowel syndrome. JGH Open 2018;2:178-81. [PMID: 30483586 DOI: 10.1002/jgh3.12069] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
310 Schumann D, Cramer H. Letter: all or nothing-placebo effects in a non-drug clinical trial in IBS. Authors' reply. Aliment Pharmacol Ther 2018;48:106-7. [PMID: 29882979 DOI: 10.1111/apt.14686] [Reference Citation Analysis]
311 Huaman JW, Mego M, Manichanh C, Cañellas N, Cañueto D, Segurola H, Jansana M, Malagelada C, Accarino A, Vulevic J, Tzortzis G, Gibson G, Saperas E, Guarner F, Azpiroz F. Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders. Gastroenterology 2018;155:1004-7. [PMID: 29964041 DOI: 10.1053/j.gastro.2018.06.045] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
312 Schnabel L, Buscail C, Sabate JM, Bouchoucha M, Kesse-Guyot E, Allès B, Touvier M, Monteiro CA, Hercberg S, Benamouzig R, Julia C. Association Between Ultra-Processed Food Consumption and Functional Gastrointestinal Disorders: Results From the French NutriNet-Santé Cohort. Am J Gastroenterol 2018;113:1217-28. [PMID: 29904158 DOI: 10.1038/s41395-018-0137-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 69] [Article Influence: 12.8] [Reference Citation Analysis]
313 Sundin J, Öhman L, Simrén M. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases. Psychosom Med 2017;79:857-67. [PMID: 28422780 DOI: 10.1097/PSY.0000000000000470] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
314 Yan YL, Gänzle MG. Structure and function relationships of the binding of β- and ɑ-galactosylated oligosaccharides to K88 fimbriae of enterotoxigenic Escherichia coli. International Dairy Journal 2018;81:104-12. [DOI: 10.1016/j.idairyj.2018.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
315 Chen M, Tang TC, Wang Y, Shui J, Xiao XH, Lan X, Yu P, Zhang C, Wang SH, Yao J, Zheng H, Huang DQ. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48:160-168. [PMID: 29856472 DOI: 10.1111/apt.14817] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
316 Dolan R, Chey WD, Eswaran S. The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs. Expert Rev Gastroenterol Hepatol 2018;12:607-15. [PMID: 29764234 DOI: 10.1080/17474124.2018.1476138] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
317 Testa A, Imperatore N, Rispo A, Rea M, Tortora R, Nardone OM, Lucci L, Accarino G, Caporaso N, Castiglione F. Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease. Dig Dis. 2018;36:271-280. [PMID: 29763907 DOI: 10.1159/000489487] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
318 Turco R, Salvatore S, Miele E, Romano C, Marseglia GL, Staiano A. Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics. Ital J Pediatr 2018;44:53. [PMID: 29764491 DOI: 10.1186/s13052-018-0495-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
319 Struyf N, Vandewiele H, Herrera-Malaver B, Verspreet J, Verstrepen KJ, Courtin CM. Kluyveromyces marxianus yeast enables the production of low FODMAP whole wheat breads. Food Microbiol 2018;76:135-45. [PMID: 30166134 DOI: 10.1016/j.fm.2018.04.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
320 Bennet SMP, Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, Öhman L, Simrén M. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut 2018;67:872-81. [PMID: 28416515 DOI: 10.1136/gutjnl-2016-313128] [Cited by in Crossref: 116] [Cited by in F6Publishing: 111] [Article Influence: 29.0] [Reference Citation Analysis]
321 Yepes IJ, Múnera MN, Martelo C. [Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols, and quality of life in patients with irritable bowel syndrome in Colombia]. Biomedica 2018;38:61-8. [PMID: 29809329 DOI: 10.7705/biomedica.v38i0.3443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
322 Song KH, Jung HK, Kim HJ, Koo HS, Kwon YH, Shin HD, Lim HC, Shin JE, Kim SE, Cho DH, Kim JH, Kim HJ; Clinical Practice Guidelines Group Under the Korean Society of Neurogastroenterology and Motility. Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. J Neurogastroenterol Motil. 2018;24:197-215. [PMID: 29605976 DOI: 10.5056/jnm17145] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
323 Ankersen DV, Weimers P, Burisch J. Whats 'App-ening': the help of new technologies in nutrition in digestive diseases. Curr Opin Clin Nutr Metab Care. 2017;20:426-431. [PMID: 28768297 DOI: 10.1097/mco.0000000000000399] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
324 Tursi A. Dietary pattern and colonic diverticulosis. Curr Opin Clin Nutr Metab Care 2017;20:409-13. [PMID: 28768296 DOI: 10.1097/MCO.0000000000000403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
325 Bajaj JS, Barbara G, DuPont HL, Mearin F, Gasbarrini A, Tack J. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Dig Liver Dis 2018;50:741-9. [PMID: 29807873 DOI: 10.1016/j.dld.2018.04.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
326 Chumpitazi BP, Lim J, McMeans AR, Shulman RJ, Hamaker BR. Evaluation of FODMAP Carbohydrates Content in Selected Foods in the United States. J Pediatr. 2018;199:252-255. [PMID: 29706489 DOI: 10.1016/j.jpeds.2018.03.038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
327 Baranguán Castro ML, Ros Arnal I, García Romero R, Rodríguez Martínez G, Ubalde Sainz E. [Implementation of a low FODMAP diet for functional abdominal pain]. An Pediatr (Engl Ed) 2019;90:180-6. [PMID: 29685830 DOI: 10.1016/j.anpedi.2018.02.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
328 Bhesania N, Cresci GAM. A nutritional approach for managing irritable bowel syndrome. Curr Opin Pediatr 2017;29:584-91. [PMID: 28737582 DOI: 10.1097/MOP.0000000000000536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
329 Yang Y, Chen G, Yang Q, Ye J, Cai X, Tsering P, Cheng X, Hu C, Zhang S, Cao P. Gut microbiota drives the attenuation of dextran sulphate sodium-induced colitis by Huangqin decoction. Oncotarget 2017;8:48863-74. [PMID: 28415628 DOI: 10.18632/oncotarget.16458] [Cited by in Crossref: 44] [Cited by in F6Publishing: 66] [Article Influence: 11.0] [Reference Citation Analysis]
330 Ontiveros N, Rodríguez-Bellegarrigue CI, Galicia-Rodríguez G, Vergara-Jiménez MJ, Zepeda-Gómez EM, Arámburo-Galvez JG, Gracia-Valenzuela MH, Cabrera-Chávez F. Prevalence of Self-Reported Gluten-Related Disorders and Adherence to a Gluten-Free Diet in Salvadoran Adult Population. Int J Environ Res Public Health 2018;15:E786. [PMID: 29670007 DOI: 10.3390/ijerph15040786] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
331 Healey GR, Murphy R, Brough L, Butts CA, Coad J. Interindividual variability in gut microbiota and host response to dietary interventions. Nutr Rev 2017;75:1059-80. [PMID: 29190368 DOI: 10.1093/nutrit/nux062] [Cited by in Crossref: 73] [Cited by in F6Publishing: 93] [Article Influence: 18.3] [Reference Citation Analysis]
332 Dieterich W, Schuppan D, Schink M, Schwappacher R, Wirtz S, Agaimy A, Neurath MF, Zopf Y. Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity. Clin Nutr. 2018;38:697-707. [PMID: 29653862 DOI: 10.1016/j.clnu.2018.03.017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 10.5] [Reference Citation Analysis]
333 Lis DM, Stellingwerff T, Kitic CM, Fell JW, Ahuja KDK. Low FODMAP: A Preliminary Strategy to Reduce Gastrointestinal Distress in Athletes. Med Sci Sports Exerc 2018;50:116-23. [PMID: 28891824 DOI: 10.1249/MSS.0000000000001419] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
334 Pirkola L, Laatikainen R, Loponen J, Hongisto SM, Hillilä M, Nuora A, Yang B, Linderborg KM, Freese R. Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill® study. World J Gastroenterol 2018; 24(11): 1259-1268 [PMID: 29568206 DOI: 10.3748/wjg.v24.i11.1259] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
335 Singh P, Mitsuhashi S, Ballou S, Rangan V, Sommers T, Cheng V, Iturrino-Moreda J, Friedlander D, Nee J, Lembo A. Demographic and Dietary Associations of Chronic Diarrhea in a Representative Sample of Adults in the United States. Am J Gastroenterol 2018;113:593-600. [PMID: 29610515 DOI: 10.1038/ajg.2018.24] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
336 Gawron AJ, Bielefeldt K. Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome With Eluxadoline. Clinical Gastroenterology and Hepatology 2018;16:378-384.e2. [DOI: 10.1016/j.cgh.2017.08.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
337 Yao CK, Chu NHS, Tan VPY. Breath Hydrogen Testing in East and Southeast Asia. Journal of Clinical Gastroenterology 2018;52:185-93. [DOI: 10.1097/mcg.0000000000000943] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
338 Pourmand H, Keshteli AH, Saneei P, Daghaghzadeh H, Esmaillzadeh A, Adibi P. Adherence to a Low FODMAP Diet in Relation to Symptoms of Irritable Bowel Syndrome in Iranian Adults. Dig Dis Sci 2018;63:1261-9. [PMID: 29497906 DOI: 10.1007/s10620-018-4986-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
339 Rodiño-Janeiro BK, Vicario M, Alonso-Cotoner C, Pascua-García R, Santos J. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Adv Ther 2018;35:289-310. [PMID: 29498019 DOI: 10.1007/s12325-018-0673-5] [Cited by in Crossref: 101] [Cited by in F6Publishing: 90] [Article Influence: 25.3] [Reference Citation Analysis]
340 Aasbrenn M, Lydersen S, Farup PG. A Conservative Weight Loss Intervention Relieves Bowel Symptoms in Morbidly Obese Subjects with Irritable Bowel Syndrome: A Prospective Cohort Study. J Obes 2018;2018:3732753. [PMID: 29686892 DOI: 10.1155/2018/3732753] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
341 Richardson DP, Ansell J, Drummond LN. The nutritional and health attributes of kiwifruit: a review. Eur J Nutr 2018;57:2659-76. [PMID: 29470689 DOI: 10.1007/s00394-018-1627-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 83] [Article Influence: 13.8] [Reference Citation Analysis]
342 Zahedi MJ, Behrouz V, Azimi M. Low fermentable oligo-di-mono-saccharides and polyols diet vs general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial. J Gastroenterol Hepatol. 2018;33:1192-1199. [PMID: 29159993 DOI: 10.1111/jgh.14051] [Cited by in Crossref: 32] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
343 Wiley JW, Chang L. Functional Bowel Disorders. Gastroenterology 2018;155:1-4. [PMID: 29454798 DOI: 10.1053/j.gastro.2018.02.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
344 Azpiroz F, Molne L, Mendez S, Nieto A, Manichanh C, Mego M, Accarino A, Santos J, Sailer M, Theis S, Guarner F. Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function. J Clin Gastroenterol 2017;51:619-25. [PMID: 27680592 DOI: 10.1097/MCG.0000000000000723] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
345 Chu NHS, Yao CK, Tan VPY. Food Therapy in Sinosphere Asia. Journal of Clinical Gastroenterology 2018;52:105-13. [DOI: 10.1097/mcg.0000000000000932] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
346 Biasini B, Marchi L, Angelino D, Bedogni G, Zavaroni I, Pruneti C, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Passeri G, Ventura M, Del Rio D, Martini D. Claimed effects, outcome variables and methods of measurement for health claims on foods related to the gastrointestinal tract proposed under regulation (EC) 1924/2006. International Journal of Food Sciences and Nutrition 2018;69:771-804. [DOI: 10.1080/09637486.2018.1427220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
347 Whelan K, Martin LD, Staudacher HM, Lomer MCE. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet 2018;31:239-55. [DOI: 10.1111/jhn.12530] [Cited by in Crossref: 97] [Cited by in F6Publishing: 102] [Article Influence: 24.3] [Reference Citation Analysis]
348 Jung H. Review of the Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. Korean J Gastroenterol 2018;72:252. [DOI: 10.4166/kjg.2018.72.5.252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
349 Chumpitazi BP, Weidler EM, Shulman RJ. Lactulose Breath Test Gas Production in Childhood IBS Is Associated With Intestinal Transit and Bowel Movement Frequency. J Pediatr Gastroenterol Nutr 2017;64:541-5. [PMID: 27276436 DOI: 10.1097/MPG.0000000000001295] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
350 de Oliveira EP. Runner's diarrhea: what is it, what causes it, and how can it be prevented? Curr Opin Gastroenterol 2017;33:41-6. [PMID: 27798441 DOI: 10.1097/MOG.0000000000000322] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
351 Chang L, Di Lorenzo C, Farrugia G, Hamilton FA, Mawe GM, Pasricha PJ, Wiley JW. Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research. Gastroenterology. 2018;154:723-735. [PMID: 29288656 DOI: 10.1053/j.gastro.2017.12.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
352 Lee HJ, Park KS. [Bloating]. Korean J Gastroenterol 2017;70:288-95. [PMID: 29277091 DOI: 10.4166/kjg.2017.70.6.288] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
353 Chen BR, Du LJ, He HQ, Kim JJ, Zhao Y, Zhang YW, Luo L, Dai N. Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model. World J Gastroenterol 2017; 23(47): 8321-8333 [PMID: 29307992 DOI: 10.3748/wjg.v23.i47.8321] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
354 Pourmand H, Esmaillzadeh A. Consumption of a Low Fermentable Oligo-, Di-, Mono-saccharides, and Polyols Diet and Irritable Bowel Syndrome: A Systematic Review. Int J Prev Med 2017;8:104. [PMID: 29416833 DOI: 10.4103/ijpvm.IJPVM_175_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
355 Kashyap PC, Chia N, Nelson H, Segal E, Elinav E. Microbiome at the Frontier of Personalized Medicine. Mayo Clin Proc 2017;92:1855-64. [PMID: 29202942 DOI: 10.1016/j.mayocp.2017.10.004] [Cited by in Crossref: 69] [Cited by in F6Publishing: 84] [Article Influence: 13.8] [Reference Citation Analysis]
356 Limketkai BN, Wolf A, Parian AM. Nutritional Interventions in the Patient with Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2018;47:155-177. [PMID: 29413010 DOI: 10.1016/j.gtc.2017.09.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
357 Limketkai BN, Sepulveda R, Hing T, Shah ND, Choe M, Limsui D, Shah S. Prevalence and factors associated with gluten sensitivity in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2018;53:147-51. [DOI: 10.1080/00365521.2017.1409364] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
358 Konturek PC, Zopf Y. Therapeutische Modulation der Darmmikrobiota beim Reizdarmsyndrom: Von Probiotika bis zur fäkalen Mikrobiota-Therapie. MMW - Fortschritte der Medizin 2017;159:1-5. [DOI: 10.1007/s15006-017-0338-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
359 Chatila R, Merhi M, Hariri E, Sabbah N, Deeb ME. Irritable bowel syndrome: prevalence, risk factors in an adult Lebanese population. BMC Gastroenterol 2017;17:137. [PMID: 29197339 DOI: 10.1186/s12876-017-0698-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
360 Eswaran S, Chey WD, Jackson K, Pillai S, Chey SW, Han-markey T. A Diet Low in Fermentable Oligo-, Di-, and Monosaccharides and Polyols Improves Quality of Life and Reduces Activity Impairment in Patients With Irritable Bowel Syndrome and Diarrhea. Clinical Gastroenterology and Hepatology 2017;15:1890-1899.e3. [DOI: 10.1016/j.cgh.2017.06.044] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 12.0] [Reference Citation Analysis]
361 Sabaté J. Syndrome de l’intestin irritable. Actualités concernant les mécanismes et la prise en charge. Douleur analg 2017;30:205-16. [DOI: 10.1007/s11724-017-0533-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
362 Zhou SY, Gillilland M, Wu X, Leelasinjaroen P, Zhang G, Zhou H, Ye B, Lu Y, Owyang C. FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction. J Clin Invest. 2018;128:267-280. [PMID: 29202473 DOI: 10.1172/jci92390] [Cited by in Crossref: 68] [Cited by in F6Publishing: 80] [Article Influence: 13.6] [Reference Citation Analysis]
363 Silk DBA, Bowling T. Pathophysiology of Enteral Feeding Diarrhea: The Intestinal Responses to Enteral Feeding Rather Than Any Role of FODMAPs. JPEN J Parenter Enteral Nutr 2017;41:1259-61. [DOI: 10.1177/0148607117690520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
364 Eswaran S, Farida JP, Green J, Miller JD, Chey WD. Nutrition in the management of gastrointestinal diseases and disorders: the evidence for the low FODMAP diet. Curr Opin Pharmacol. 2017;37:151-157. [PMID: 29156449 DOI: 10.1016/j.coph.2017.10.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
365 DeGeorge KC, Frye JW, Stein KM, Rollins LK, McCarter DF. Celiac Disease and Gluten Sensitivity. Prim Care 2017;44:693-707. [PMID: 29132529 DOI: 10.1016/j.pop.2017.07.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
366 Stone AL, Wilson AC. Transmission of risk from parents with chronic pain to offspring: an integrative conceptual model. Pain 2016;157:2628-39. [PMID: 27380502 DOI: 10.1097/j.pain.0000000000000637] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 14.8] [Reference Citation Analysis]
367 Zia J, Chung CF, Xu K, Dong Y, Schenk JM, Cain K, Munson S, Heitkemper MM. Inter-Rater Reliability of Provider Interpretations of Irritable Bowel Syndrome Food and Symptom Journals. J Clin Med 2017;6:E105. [PMID: 29113044 DOI: 10.3390/jcm6110105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
368 Tuck CJ, Vanner SJ. Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions. Neurogastroenterol Motil 2018;30:e13238. [DOI: 10.1111/nmo.13238] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
369 Linedale EC, Mikocka-walus A, Vincent AD, Gibson PR, Andrews JM. Performance of an algorithm-based approach to the diagnosis and management of functional gastrointestinal disorders: A pilot trial. Neurogastroenterol Motil 2018;30:e13243. [DOI: 10.1111/nmo.13243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
370 Skodje GI, Sarna VK, Minelle IH, Rolfsen KL, Muir JG, Gibson PR, Veierød MB, Henriksen C, Lundin KEA. Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. Gastroenterology 2018;154:529-539.e2. [PMID: 29102613 DOI: 10.1053/j.gastro.2017.10.040] [Cited by in Crossref: 174] [Cited by in F6Publishing: 183] [Article Influence: 34.8] [Reference Citation Analysis]
371 Piper MS, Saad RJ. Diabetes Mellitus and the Colon. Curr Treat Options Gastroenterol. 2017;15:460-474. [PMID: 29063998 DOI: 10.1007/s11938-017-0151-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
372 Harris LA, Baffy N. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Postgrad Med 2017;129:872-88. [PMID: 28936910 DOI: 10.1080/00325481.2017.1383819] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
373 Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017;11:196-208. [PMID: 28274108 DOI: 10.5009/gnl16126] [Cited by in Crossref: 86] [Cited by in F6Publishing: 66] [Article Influence: 17.2] [Reference Citation Analysis]
374 Cremon C, Guglielmetti S, Gargari G, Taverniti V, Castellazzi AM, Valsecchi C, Tagliacarne C, Fiore W, Bellini M, Bertani L, Gambaccini D, Cicala M, Germanà B, Vecchi M, Pagano I, Barbaro MR, Bellacosa L, Stanghellini V, Barbara G. Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial. United European Gastroenterol J 2018;6:604-13. [PMID: 29881616 DOI: 10.1177/2050640617736478] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 10.2] [Reference Citation Analysis]
375 Linedale EC, Andrews JM. Diagnosis and management of irritable bowel syndrome: a guide for the generalist. Med J Aust. 2017;207:309-315. [PMID: 28954618 DOI: 10.5694/mja17.00457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
376 Gibson PR, Burgell RE. Easing Concerns About the Low FODMAP Diet in Patients With Irritable Bowel Syndrome. Gastroenterology 2017;153:886-7. [DOI: 10.1053/j.gastro.2017.08.055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
377 Pöhnl T, Böttcher C, Schulz H, Stürtz M, Widder S, Carle R, Schweiggert RM. Comparison of high performance anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD) and ultra-high performance liquid chromatography with evaporative light scattering (UHPLC-ELSD) for the analyses of fructooligosaccharides in onion ( Allium cepa L.). Journal of Food Composition and Analysis 2017;63:148-56. [DOI: 10.1016/j.jfca.2017.08.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
378 Nanayakkara WS, Gearry RB, Muir JG, O'Brien L, Wilkinson TJ, Williman JA, Skidmore PML. Gastrointestinal Symptoms and FODMAP Intake of Aged-Care Residents from Christchurch, New Zealand. Nutrients. 2017;9. [PMID: 28961170 DOI: 10.3390/nu9101083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
379 Chumpitazi BP, McMeans AR, Vaughan A, Ali A, Orlando S, Elsaadi A, Shulman RJ. Fructans Exacerbate Symptoms in a Subset of Children With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 2018;16:219-225.e1. [PMID: 28970147 DOI: 10.1016/j.cgh.2017.09.043] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
380 Clarke ST, Brooks SPJ, Inglis GD, Yanke LJ, Green J, Petronella N, Ramdath DD, Bercik P, Green-Johnson JM, Kalmokoff M. Impact of β2-1 fructan on faecal community change: results from a placebo-controlled, randomised, double-blinded, cross-over study in healthy adults. Br J Nutr 2017;118:441-53. [PMID: 28954640 DOI: 10.1017/S0007114517002318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
381 Moayyedi P, Mearin F, Azpiroz F, Andresen V, Barbara G, Corsetti M, Emmanuel A, Hungin APS, Layer P, Stanghellini V, Whorwell P, Zerbib F, Tack J. Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice. United European Gastroenterol J. 2017;5:773-788. [PMID: 29026591 DOI: 10.1177/2050640617731968] [Cited by in Crossref: 67] [Cited by in F6Publishing: 53] [Article Influence: 13.4] [Reference Citation Analysis]
382 Struyf N, Laurent J, Verspreet J, Verstrepen KJ, Courtin CM. Saccharomyces cerevisiae and Kluyveromyces marxianus Cocultures Allow Reduction of Fermentable Oligo-, Di-, and Monosaccharides and Polyols Levels in Whole Wheat Bread. J Agric Food Chem 2017;65:8704-13. [PMID: 28869377 DOI: 10.1021/acs.jafc.7b02793] [Cited by in Crossref: 32] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
383 Harvie R, Walmsley R, Schultz M; New Zealand Society of Gastroenterology. "We are what our bacteria eat": The role of bacteria in personalizing nutrition therapy in gastrointestinal conditions. J Gastroenterol Hepatol 2017;32:352-7. [PMID: 27248703 DOI: 10.1111/jgh.13462] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
384 Ireton-jones C. The low FODMAP diet: fundamental therapy in the management of irritable bowel syndrome. Current Opinion in Clinical Nutrition & Metabolic Care 2017;20:414-9. [DOI: 10.1097/mco.0000000000000398] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
385 Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients. 2017;9. [PMID: 28846594 DOI: 10.3390/nu9090940] [Cited by in Crossref: 113] [Cited by in F6Publishing: 83] [Article Influence: 22.6] [Reference Citation Analysis]
386 Savino P. Knowledge of Constituent Ingredients in Enteral Nutrition Formulas Can Make a Difference in Patient Response to Enteral Feeding. Nutr Clin Pract 2017. [DOI: 10.1177/0884533617724759] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
387 Moding M, Ohlsson B. The role of fermentable carbohydrates and beverages in the symptomatology of functional gastrointestinal disease. Scand J Gastroenterol 2017;52:1224-34. [PMID: 28826271 DOI: 10.1080/00365521.2017.1365931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
388 Tuck CJ, Taylor KM, Gibson PR, Barrett JS, Muir JG. Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment. Am J Gastroenterol 2018;113:124-34. [PMID: 28809383 DOI: 10.1038/ajg.2017.245] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 5.4] [Reference Citation Analysis]
389 Bayer SB, Gearry RB, Drummond LN. Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Crit Rev Food Sci Nutr 2018;58:2432-52. [PMID: 28557573 DOI: 10.1080/10408398.2017.1327841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
390 Mazzawi T, El-Salhy M. Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). Int J Mol Med 2017;40:943-52. [PMID: 28849091 DOI: 10.3892/ijmm.2017.3096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
391 Barrett JS. How to institute the low-FODMAP diet. J Gastroenterol Hepatol. 2017;32 Suppl 1:8-10. [PMID: 28244669 DOI: 10.1111/jgh.13686] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
392 Tan VP. The low-FODMAP diet in the management of functional dyspepsia in East and Southeast Asia. J Gastroenterol Hepatol. 2017;32 Suppl 1:46-52. [PMID: 28244670 DOI: 10.1111/jgh.13697] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
393 Halmos EP. When the low FODMAP diet does not work. J Gastroenterol Hepatol. 2017;32 Suppl 1:69-72. [PMID: 28244666 DOI: 10.1111/jgh.13701] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
394 O'Keeffe M, Lomer MC. Who should deliver the low FODMAP diet and what educational methods are optimal: a review. J Gastroenterol Hepatol. 2017;32 Suppl 1:23-26. [PMID: 28244661 DOI: 10.1111/jgh.13690] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
395 Wilson B, Whelan K. Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders. J Gastroenterol Hepatol 2017;32 Suppl 1:64-8. [PMID: 28244671 DOI: 10.1111/jgh.13700] [Cited by in Crossref: 119] [Cited by in F6Publishing: 127] [Article Influence: 23.8] [Reference Citation Analysis]
396 Gibson PR. The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy? J Gastroenterol Hepatol. 2017;32 Suppl 1:32-35. [PMID: 28244668 DOI: 10.1111/jgh.13693] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
397 Halmos EP, Biesiekierski JR, Newnham ED, Burgell RE, Muir JG, Gibson PR. Inaccuracy of patient-reported descriptions of and satisfaction with bowel actions in irritable bowel syndrome. Neurogastroenterol Motil. 2018;30. [PMID: 28799291 DOI: 10.1111/nmo.13187] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
398 Fan W, Ding C, Xu N, Zong S, Ma P, Gu B. Close association between intestinal microbiota and irritable bowel syndrome. Eur J Clin Microbiol Infect Dis 2017;36:2303-17. [DOI: 10.1007/s10096-017-3060-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
399 Wong WM. Restriction of FODMAP in the management of bloating in irritable bowel syndrome. Singapore Med J 2016;57:476-84. [PMID: 27664186 DOI: 10.11622/smedj.2016152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
400 Masuy I, Van Oudenhove L, Tack J, Biesiekierski JR. Effect of intragastric FODMAP infusion on upper gastrointestinal motility, gastrointestinal, and psychological symptoms in irritable bowel syndrome vs healthy controls. Neurogastroenterol Motil 2018;30. [PMID: 28762592 DOI: 10.1111/nmo.13167] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
401 Henggeler JC, Veríssimo M, Ramos F. Non-coeliac gluten sensitivity: A review of the literature. Trends in Food Science & Technology 2017;66:84-92. [DOI: 10.1016/j.tifs.2017.05.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
402 Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut 2017;66:1517-27. [PMID: 28592442 DOI: 10.1136/gutjnl-2017-313750] [Cited by in Crossref: 173] [Cited by in F6Publishing: 144] [Article Influence: 34.6] [Reference Citation Analysis]
403 Malagelada JR, Accarino A, Azpiroz F. Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge. American Journal of Gastroenterology 2017;112:1221-31. [DOI: 10.1038/ajg.2017.129] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
404 Schumann D, Klose P, Lauche R, Dobos G, Langhorst J, Cramer H. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Nutrition 2018;45:24-31. [PMID: 29129233 DOI: 10.1016/j.nut.2017.07.004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 17.6] [Reference Citation Analysis]
405 Misselwitz B, Fox M. What is normal and abnormal in lactose digestion? Lancet Gastroenterol Hepatol 2017;2:696-7. [PMID: 28690132 DOI: 10.1016/S2468-1253(17)30180-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
406 Harvie RM, Chisholm AW, Bisanz JE, Burton JP, Herbison P, Schultz K, Schultz M. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. World J Gastroenterol 2017; 23(25): 4632-4643 [PMID: 28740352 DOI: 10.3748/wjg.v23.i25.4632] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 65] [Article Influence: 15.4] [Reference Citation Analysis]
407 Krogsgaard LR, Lyngesen M, Bytzer P. Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome-getting the facts right. Authors' reply. Aliment Pharmacol Ther 2017;46:386-7. [PMID: 28677288 DOI: 10.1111/apt.14165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
408 Gibson PR, Halmos EP, Muir JG. Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome-getting the facts right. Aliment Pharmacol Ther 2017;46:385-6. [DOI: 10.1111/apt.14150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
409 Lenhart A, Chey WD. A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome. Adv Nutr 2017;8:587-96. [PMID: 28710145 DOI: 10.3945/an.117.015560] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
410 McIntosh K, Reed DE, Schneider T, Dang F, Keshteli AH, De Palma G, Madsen K, Bercik P, Vanner S. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut 2017;66:1241-51. [PMID: 26976734 DOI: 10.1136/gutjnl-2015-311339] [Cited by in Crossref: 227] [Cited by in F6Publishing: 221] [Article Influence: 45.4] [Reference Citation Analysis]
411 Vincenzi M, Del Ciondolo I, Pasquini E, Gennai K, Paolini B. Effects of a Low FODMAP Diet and Specific Carbohydrate Diet on Symptoms and Nutritional Adequacy of Patients with Irritable Bowel Syndrome: Preliminary Results of a Single-blinded Randomized Trial. J Transl Int Med. 2017;5:120-126. [PMID: 28721345 DOI: 10.1515/jtim-2017-0004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
412 Aasbrenn M, Høgestøl I, Eribe I, Kristinsson J, Lydersen S, Mala T, Farup PG. Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study. BMC Obes 2017;4:22. [PMID: 28680646 DOI: 10.1186/s40608-017-0159-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
413 Marlicz W, Yung DE, Skonieczna-Żydecka K, Loniewski I, van Hemert S, Loniewska B, Koulaouzidis A. From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases. Expert Rev Gastroenterol Hepatol 2017;11:961-78. [PMID: 28618973 DOI: 10.1080/17474124.2017.1343664] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
414 Mizuno S, Masaoka T, Naganuma M, Kishimoto T, Kitazawa M, Kurokawa S, Nakashima M, Takeshita K, Suda W, Mimura M, Hattori M, Kanai T. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome. Digestion 2017;96:29-38. [PMID: 28628918 DOI: 10.1159/000471919] [Cited by in Crossref: 56] [Cited by in F6Publishing: 67] [Article Influence: 11.2] [Reference Citation Analysis]
415 Iacovou M, Mulcahy EC, Truby H, Barrett JS, Gibson PR, Muir JG. Reducing the maternal dietary intake of indigestible and slowly absorbed short-chain carbohydrates is associated with improved infantile colic: a proof-of-concept study. J Hum Nutr Diet 2018;31:256-65. [PMID: 28631347 DOI: 10.1111/jhn.12488] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
416 Staudacher HM, Lomer MCE, Farquharson FM, Louis P, Fava F, Franciosi E, Scholz M, Tuohy KM, Lindsay JO, Irving PM, Whelan K. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial. Gastroenterology. 2017;153:936-947. [PMID: 28625832 DOI: 10.1053/j.gastro.2017.06.010] [Cited by in Crossref: 189] [Cited by in F6Publishing: 203] [Article Influence: 37.8] [Reference Citation Analysis]
417 Harris LA, Umar SB, Baffy N, Heitkemper MM. Irritable Bowel Syndrome and Female Patients. Gastroenterol Clin North Am 2016;45:179-204. [PMID: 27261893 DOI: 10.1016/j.gtc.2016.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
418 Pace LA, Crowe SE. Complex Relationships Between Food, Diet, and the Microbiome. Gastroenterol Clin North Am 2016;45:253-65. [PMID: 27261897 DOI: 10.1016/j.gtc.2016.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
419 Cozma-Petruţ A, Loghin F, Miere D, Dumitraşcu DL. Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients!. World J Gastroenterol 2017; 23(21): 3771-3783 [PMID: 28638217 DOI: 10.3748/wjg.v23.i21.3771] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 47] [Article Influence: 13.2] [Reference Citation Analysis]
420 Weaver KR, Melkus GD, Henderson WA. Irritable Bowel Syndrome. Am J Nurs 2017;117:48-55. [PMID: 28541989 DOI: 10.1097/01.NAJ.0000520253.57459.01] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
421 Kułak-Bejda A, Bejda G, Waszkiewicz N. Antidepressants for irritable bowel syndrome-A systematic review. Pharmacol Rep 2017;69:1366-79. [PMID: 29132094 DOI: 10.1016/j.pharep.2017.05.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
422 Rasmussen HE, Hamaker B, Rajan KB, Mutlu E, Green SJ, Brown M, Kaur A, Keshavarzian A. Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial. Nutr Res 2017;44:27-37. [PMID: 28821315 DOI: 10.1016/j.nutres.2017.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
423 Erickson J, Wang Q, Slavin J. White Grape Juice Elicits a Lower Breath Hydrogen Response Compared with Apple Juice in Healthy Human Subjects: A Randomized Controlled Trial. Journal of the Academy of Nutrition and Dietetics 2017;117:908-13. [DOI: 10.1016/j.jand.2017.01.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
424 Cotter TG, Gurney M, Loftus CG. Gas and Bloating-Controlling Emissions: A Case-Based Review for the Primary Care Provider. Mayo Clin Proc 2016;91:1105-13. [PMID: 27492915 DOI: 10.1016/j.mayocp.2016.04.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
425 Erickson J, Korczak R, Wang Q, Slavin J. Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial. Nutr J 2017;16:35. [PMID: 28545589 DOI: 10.1186/s12937-017-0256-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
426 Zhan YL, Zhan YA, Dai SX. Is a low FODMAP diet beneficial for patients with inflammatory bowel disease? A meta-analysis and systematic review. Clin Nutr 2018;37:123-9. [PMID: 28587774 DOI: 10.1016/j.clnu.2017.05.019] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
427 Pedersen N, Ankersen DV, Felding M, Wachmann H, Végh Z, Molzen L, Burisch J, Andersen JR, Munkholm P. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol 2017; 23(18): 3356-3366 [PMID: 28566897 DOI: 10.3748/wjg.v23.i18.3356] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 82] [Article Influence: 19.0] [Reference Citation Analysis]
428 Rao VL, Micic D, Kim KE. Primary Care Evaluation and Management of Gastroenterologic Issues in Women. Obstet Gynecol Clin North Am 2016;43:347-66. [PMID: 27212096 DOI: 10.1016/j.ogc.2016.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
429 Irvine EJ, Tack J, Crowell MD, Gwee KA, Ke M, Schmulson MJ, Whitehead WE, Spiegel B. Design of Treatment Trials for Functional Gastrointestinal Disorders. Gastroenterology. 2016;150:1469-1480.e1. [PMID: 27147123 DOI: 10.1053/j.gastro.2016.02.010] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 11.8] [Reference Citation Analysis]
430 Karkar R, Schroeder J, Epstein DA, Pina LR, Scofield J, Fogarty J, Kientz JA, Munson SA, Vilardaga R, Zia J. TummyTrials: A Feasibility Study of Using Self-Experimentation to Detect Individualized Food Triggers. Proc SIGCHI Conf Hum Factor Comput Syst 2017;2017:6850-63. [PMID: 28516175 DOI: 10.1145/3025453.3025480] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 10.2] [Reference Citation Analysis]
431 Ikechi R, Fischer BD, DeSipio J, Phadtare S. Irritable Bowel Syndrome: Clinical Manifestations, Dietary Influences, and Management. Healthcare (Basel). 2017;5. [PMID: 28445436 DOI: 10.3390/healthcare5020021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
432 Krogsgaard LR, Lyngesen M, Bytzer P. Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome. Aliment Pharmacol Ther 2017;45:1506-13. [PMID: 28440580 DOI: 10.1111/apt.14065] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
433 Zannini E, Arendt EK. Low FODMAPs and gluten-free foods for irritable bowel syndrome treatment: Lights and shadows. Food Res Int 2018;110:33-41. [PMID: 30029704 DOI: 10.1016/j.foodres.2017.04.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
434 Zhou K. Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies. J Funct Foods 2017;33:194-201. [PMID: 30416539 DOI: 10.1016/j.jff.2017.03.045] [Cited by in Crossref: 76] [Cited by in F6Publishing: 104] [Article Influence: 15.2] [Reference Citation Analysis]
435 Eswaran S. Low FODMAP in 2017: Lessons learned from clinical trials and mechanistic studies. Neurogastroenterol Motil 2017;29:e13055. [DOI: 10.1111/nmo.13055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
436 Moore JS, Gibson PR, Perry RE, Burgell RE. Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet. Aust N Z J Obstet Gynaecol 2017;57:201-5. [PMID: 28303579 DOI: 10.1111/ajo.12594] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
437 Mazzawi T, El-Salhy M. Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. Exp Biol Med (Maywood) 2017;242:1355-62. [PMID: 28737477 DOI: 10.1177/1535370217699537] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
438 Lacy BE, Moreau JC. Diarrhea-predominant irritable bowel syndrome: Diagnosis, etiology, and new treatment considerations. J Am Assoc Nurse Pract 2016;28:393-404. [PMID: 27436200 DOI: 10.1002/2327-6924.12387] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
439 Varney J, Barrett J, Scarlata K, Catsos P, Gibson PR, Muir JG. FODMAPs: food composition, defining cutoff values and international application: Defining and adapting the low-FODMAP diet. Journal of Gastroenterology and Hepatology 2017;32:53-61. [DOI: 10.1111/jgh.13698] [Cited by in Crossref: 90] [Cited by in F6Publishing: 94] [Article Influence: 18.0] [Reference Citation Analysis]
440 Staudacher HM. Nutritional, microbiological and psychosocial implications of the low FODMAP diet: Implications of the low FODMAP diet. Journal of Gastroenterology and Hepatology 2017;32:16-9. [DOI: 10.1111/jgh.13688] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
441 Iizuka K. The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism. Nutrients 2017;9:E181. [PMID: 28241431 DOI: 10.3390/nu9020181] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
442 Ghoshal UC, Singh R. Frequency and risk factors of functional gastro-intestinal disorders in a rural Indian population: Dyspepsia and IBS in a rural Indian community. Journal of Gastroenterology and Hepatology 2017;32:378-87. [DOI: 10.1111/jgh.13465] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
443 Lee HJ, Choi JK, Ryu HS, Choi CH, Kang EH, Park KS, Min YW, Hong KS. Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil 2017;23:9-19. [PMID: 28049862 DOI: 10.5056/jnm16124] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
444 Shah SL, Lacy BE. Dietary Interventions and Irritable Bowel Syndrome: A Review of the Evidence. Curr Gastroenterol Rep. 2016;18:41. [PMID: 27372289 DOI: 10.1007/s11894-016-0517-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
445 Portincasa P, Bonfrate L, de Bari O, Lembo A, Ballou S. Irritable bowel syndrome and diet. Gastroenterol Rep (Oxf). 2017;5:11-19. [PMID: 28110300 DOI: 10.1093/gastro/gow047] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
446 Powell N, Walker MM, Talley NJ. The mucosal immune system: master regulator of bidirectional gut–brain communications. Nat Rev Gastroenterol Hepatol 2017;14:143-59. [DOI: 10.1038/nrgastro.2016.191] [Cited by in Crossref: 182] [Cited by in F6Publishing: 158] [Article Influence: 36.4] [Reference Citation Analysis]
447 Prince AC, Myers CE, Joyce T, Irving P, Lomer M, Whelan K. Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:1129-1136. [PMID: 26914438 DOI: 10.1097/mib.0000000000000708] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 22.6] [Reference Citation Analysis]
448 Mego M, Manichanh C, Accarino A, Campos D, Pozuelo M, Varela E, Vulevic J, Tzortzis G, Gibson G, Guarner F, Azpiroz F. Metabolic adaptation of colonic microbiota to galactooligosaccharides: a proof-of-concept-study. Aliment Pharmacol Ther 2017;45:670-80. [PMID: 28078750 DOI: 10.1111/apt.13931] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
449 Murtaza N, Ó Cuív P, Morrison M. Diet and the Microbiome. Gastroenterol Clin North Am 2017;46:49-60. [PMID: 28164852 DOI: 10.1016/j.gtc.2016.09.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
450 Leiby A, Vazirani M. Complementary, Integrative, and Holistic Medicine: Integrative Approaches to Pediatric Irritable Bowel Syndrome. Pediatr Rev 2016;37:e10-5. [PMID: 27037108 DOI: 10.1542/pir.2015-0036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
451 Rotbart A, Yao C, Ha N, Chrisp MD, Muir JG, Gibson PR, Kalantar-zadeh K, Ou JZ. Designing an in-vitro gas profiling system for human faecal samples. Sensors and Actuators B: Chemical 2017;238:754-64. [DOI: 10.1016/j.snb.2016.07.120] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
452 Koretz RL. JPEN Journal Club 24. Study Premise. JPEN J Parenter Enteral Nutr 2017;41:135-7. [PMID: 28031005 DOI: 10.1177/0148607116672267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
453 Zevallos VF, Raker V, Tenzer S, Jimenez-Calvente C, Ashfaq-Khan M, Rüssel N, Pickert G, Schild H, Steinbrink K, Schuppan D. Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid Cells. Gastroenterology 2017;152:1100-1113.e12. [PMID: 27993525 DOI: 10.1053/j.gastro.2016.12.006] [Cited by in Crossref: 151] [Cited by in F6Publishing: 159] [Article Influence: 25.2] [Reference Citation Analysis]
454 Harvie R, Chanyi RM, Burton JP, Schultz M. Using the Human Gastrointestinal Microbiome to Personalize Nutrition Advice: Are Registered Dietitian Nutritionists Ready for the Opportunities and Challenges? J Acad Nutr Diet. 2016; Epub ahead of print. [PMID: 27986518 DOI: 10.1016/j.jand.2016.10.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
455 Patcharatrakul T, Gonlachanvit S. Chili Peppers, Curcumins, and Prebiotics in Gastrointestinal Health and Disease. Curr Gastroenterol Rep 2016;18:19. [PMID: 26973345 DOI: 10.1007/s11894-016-0494-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
456 Michalak A, Mosińska P, Fichna J. Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer. Front Pharmacol 2016;7:459. [PMID: 27990120 DOI: 10.3389/fphar.2016.00459] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
457 Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol. 2017;312:G52-G62. [PMID: 27881403 DOI: 10.1152/ajpgi.00338.2016] [Cited by in Crossref: 104] [Cited by in F6Publishing: 103] [Article Influence: 17.3] [Reference Citation Analysis]
458 Zito FP, Polese B, Vozzella L, Gala A, Genovese D, Verlezza V, Medugno F, Santini A, Barrea L, Cargiolli M, Andreozzi P, Sarnelli G, Cuomo R. Good adherence to mediterranean diet can prevent gastrointestinal symptoms: A survey from Southern Italy. World J Gastrointest Pharmacol Ther 2016; 7(4): 564-571 [PMID: 27867690 DOI: 10.4292/wjgpt.v7.i4.564] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
459 Uno Y, van Velkinburgh JC. Logical hypothesis: Low FODMAP diet to prevent diverticulitis. World J Gastrointest Pharmacol Ther 2016;7:503-12. [PMID: 27867683 DOI: 10.4292/wjgpt.v7.i4.503] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
460 Caubet JC, Szajewska H, Shamir R, Nowak-Węgrzyn A. Non-IgE-mediated gastrointestinal food allergies in children. Pediatr Allergy Immunol 2017;28:6-17. [PMID: 27637372 DOI: 10.1111/pai.12659] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 9.2] [Reference Citation Analysis]
461 Skodje GI, Henriksen C, Salte T, Drivenes T, Toleikyte I, Lovik AM, Veierød MB, Lundin KE. Wheat challenge in self-reported gluten sensitivity: a comparison of scoring methods. Scandinavian Journal of Gastroenterology 2017;52:185-92. [DOI: 10.1080/00365521.2016.1244705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
462 Bordoni A, Danesi F, Di Nunzio M, Taccari A, Valli V. Ancient wheat and health: a legend or the reality? A review on KAMUT khorasan wheat. International Journal of Food Sciences and Nutrition 2017;68:278-86. [DOI: 10.1080/09637486.2016.1247434] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
463 Major G, Pritchard S, Murray K, Alappadan JP, Hoad CL, Marciani L, Gowland P, Spiller R. Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome. Gastroenterology 2017; 152: 124-133. e2. [PMID: 27746233 DOI: 10.1053/j.gastro.2016.09.062] [Cited by in Crossref: 135] [Cited by in F6Publishing: 150] [Article Influence: 22.5] [Reference Citation Analysis]
464 Eswaran SL, Chey WD, Han-Markey T, Ball S, Jackson K. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. Am J Gastroenterol. 2016;111:1824-1832. [PMID: 27725652 DOI: 10.1038/ajg.2016.434] [Cited by in Crossref: 173] [Cited by in F6Publishing: 173] [Article Influence: 28.8] [Reference Citation Analysis]
465 Lucak S, Chang L, Halpert A, Harris LA. Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therap Adv Gastroenterol 2017;10:253-75. [PMID: 28203283 DOI: 10.1177/1756283X16663396] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
466 Zia JK, Chung CF, Schroeder J, Munson SA, Kientz JA, Fogarty J, Bales E, Schenk JM, Heitkemper MM. The feasibility, usability, and clinical utility of traditional paper food and symptom journals for patients with irritable bowel syndrome. Neurogastroenterol Motil 2017;29. [PMID: 27619957 DOI: 10.1111/nmo.12935] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
467 Tuck CJ, Ross LA, Gibson PR, Barrett JS, Muir JG. Adding glucose to food and solutions to enhance fructose absorption is not effective in preventing fructose-induced functional gastrointestinal symptoms: randomised controlled trials in patients with fructose malabsorption. J Hum Nutr Diet 2017;30:73-82. [PMID: 27600184 DOI: 10.1111/jhn.12409] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
468 Smits SA, Marcobal A, Higginbottom S, Sonnenburg JL, Kashyap PC. Individualized Responses of Gut Microbiota to Dietary Intervention Modeled in Humanized Mice. mSystems 2016;1:e00098-16. [PMID: 27822551 DOI: 10.1128/mSystems.00098-16] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
469 Deng Y, Zhu Y, Dai N, Fox M. Dietary Challenge Tests: Identifying Food Intolerance as a Cause of Symptoms in Irritable Bowel Syndrome Patients. Clin Gastroenterol Hepatol 2016;14:1364-5. [PMID: 27085755 DOI: 10.1016/j.cgh.2016.04.011] [Reference Citation Analysis]
470 Zingone F, Bartalini C, Siniscalchi M, Ruotolo M, Bucci C, Morra I, Iovino P, Ciacci C. Alterations in Diets of Patients With Nonceliac Gluten Sensitivity Compared With Healthy Individuals. Clin Gastroenterol Hepatol. 2017;15:63-68.e2. [PMID: 27552857 DOI: 10.1016/j.cgh.2016.08.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
471 Patel N, Lacy B. Does Yoga Help Patients With Irritable Bowel Syndrome? Clin Gastroenterol Hepatol 2016;14:1732-4. [PMID: 27552854 DOI: 10.1016/j.cgh.2016.08.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
472 Molina-Infante J, Carroccio A. Suspected Nonceliac Gluten Sensitivity Confirmed in Few Patients After Gluten Challenge in Double-Blind, Placebo-Controlled Trials. Clin Gastroenterol Hepatol. 2017;15:339-348. [PMID: 27523634 DOI: 10.1016/j.cgh.2016.08.007] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 13.3] [Reference Citation Analysis]
473 Opekun AR, Balesh AM, Shelby HT. Use of the Biphasic (13)C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders. Biomed Res Int. 2016;2016:7952891. [PMID: 27579322 DOI: 10.1155/2016/7952891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
474 Brown K, Scott-Hoy B, Jennings LW. Response of irritable bowel syndrome with constipation patients administered a combined quebracho/conker tree/M. balsamea Willd extract. World J Gastrointest Pharmacol Ther 2016; 7(3): 463-468 [PMID: 27602249 DOI: 10.4292/wjgpt.v7.i3.463] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
475 Duboc H, Dior M, Coffin B. Le syndrome de l’intestin irritable : nouvelles pistes physiopathologiques et conséquences pratiques. La Revue de Médecine Interne 2016;37:536-43. [DOI: 10.1016/j.revmed.2015.12.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
476 Raskov H, Burcharth J, Pommergaard HC, Rosenberg J. Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes. 2016;7:365-383. [PMID: 27472486 DOI: 10.1080/19490976.2016.1218585] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 9.8] [Reference Citation Analysis]
477 Laatikainen R, Koskenpato J, Hongisto SM, Loponen J, Poussa T, Hillilä M, Korpela R. Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2016;44:460-70. [PMID: 27417338 DOI: 10.1111/apt.13726] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 10.5] [Reference Citation Analysis]
478 Halmos EP, Bogatyrev A, Ly E, Liels KL, Muir JG, Gibson PR. Challenges of Quantifying FODMAPs in Enteral Nutrition Formulas: Evaluation of Artifacts and Solutions. JPEN J Parenter Enteral Nutr 2017;41:1262-71. [PMID: 27406943 DOI: 10.1177/0148607116658763] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
479 El-Chammas K, Williams SE, Miranda A. Disaccharidase Deficiencies in Children With Chronic Abdominal Pain. JPEN J Parenter Enteral Nutr. 2017;41:463-469. [PMID: 26160252 DOI: 10.1177/0148607115594675] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
480 Peters SL, Yao CK, Philpott H, Yelland GW, Muir JG, Gibson PR. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2016;44:447-59. [PMID: 27397586 DOI: 10.1111/apt.13706] [Cited by in Crossref: 85] [Cited by in F6Publishing: 68] [Article Influence: 14.2] [Reference Citation Analysis]
481 Carmona-sánchez R, Icaza-chávez M, Bielsa-fernández M, Gómez-escudero O, Bosques-padilla F, Coss-adame E, Esquivel-ayanegui F, Flores-rendón Á, González-martínez M, Huerta-iga F, López-colombo A, Méndez-gutiérrez T, Noble-lugo A, Nogueira-de Rojas J, Raña-garibay R, Remes-troche J, Roesch-dietlen F, Schmulson M, Soto-pérez J, Tamayo J, Uscanga L, Valdovinos M, Valerio-ureña J, Zavala-solares M. Consenso mexicano sobre el síndrome de intestino irritable. Revista de Gastroenterología de México 2016;81:149-67. [DOI: 10.1016/j.rgmx.2016.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
482 Mazzawi T, El-Salhy M. Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome. Exp Ther Med. 2016;12:1398-1404. [PMID: 27588061 DOI: 10.3892/etm.2016.3491] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
483 Bascuñán KA, Vespa MC, Araya M. Celiac disease: understanding the gluten-free diet. Eur J Nutr 2017;56:449-59. [DOI: 10.1007/s00394-016-1238-5] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 15.8] [Reference Citation Analysis]
484 Boeckxstaens GE, Drug V, Dumitrascu D, Farmer AD, Hammer J, Hausken T, Niesler B, Pohl D, Pojskic L, Polster A, Simren M, Goebel-Stengel M, Van Oudenhove L, Vassallo M, Wensaas KA, Aziz Q, Houghton LA; COST Action BM1106 GENIEUR members. Phenotyping of subjects for large scale studies on patients with IBS. Neurogastroenterol Motil 2016;28:1134-47. [PMID: 27319981 DOI: 10.1111/nmo.12886] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
485 Nanayakkara WS, Skidmore PM, O'Brien L, Wilkinson TJ, Gearry RB. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 2016;9:131-142. [PMID: 27382323 DOI: 10.2147/ceg.s86798] [Cited by in Crossref: 29] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
486 Mckenzie YA, Thompson J, Gulia P, Lomer MCE; (IBS Dietetic Guideline Review Group on behalf of Gastroenterology Specialist Group of the British Dietetic Association). British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet 2016;29:576-92. [DOI: 10.1111/jhn.12386] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
487 Halmos EP. A low FODMAP diet in patients with Crohn's disease: A low FODMAP diet in Crohn's disease. Journal of Gastroenterology and Hepatology 2016;31:14-5. [DOI: 10.1111/jgh.13349] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
488 Erlichman J, Hall A, Dean A, Godwin B, Mascarenhas M. Integrative Nutrition for Pediatrics. Current Problems in Pediatric and Adolescent Health Care 2016;46:165-71. [DOI: 10.1016/j.cppeds.2015.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
489 Malagelada JR, Malagelada C. Mechanism-Oriented Therapy of Irritable Bowel Syndrome. Adv Ther 2016;33:877-93. [PMID: 27138605 DOI: 10.1007/s12325-016-0336-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
490 Weaver KR, Sherwin LB, Walitt B, Melkus GD, Henderson WA. Neuroimaging the brain-gut axis in patients with irritable bowel syndrome. World J Gastrointest Pharmacol Ther 2016; 7(2): 320-333 [PMID: 27158548 DOI: 10.4292/wjgpt.v7.i2.320] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
491 Capili B, Anastasi JK, Chang M. Addressing the Role of Food in Irritable Bowel Syndrome Symptom Management. J Nurse Pract. 2016;12:324-329. [PMID: 27429601 DOI: 10.1016/j.nurpra.2015.12.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
492 Spiller R. Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res 2016;5:F1000 Faculty Rev-780. [PMID: 27158477 DOI: 10.12688/f1000research.7992.1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
493 Maagaard L, Ankersen DV, Végh Z, Burisch J, Jensen L, Pedersen N, Munkholm P. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol 2016; 22(15): 4009-4019 [PMID: 27099444 DOI: 10.3748/wjg.v22.i15.4009] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 74] [Article Influence: 14.2] [Reference Citation Analysis]
494 Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Muir JG, Gibson PR. Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. Clin Transl Gastroenterol. 2016;7:e164. [PMID: 27077959 DOI: 10.1038/ctg.2016.22] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 10.3] [Reference Citation Analysis]
495 McCarville JL, Caminero A, Verdu EF. Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol. 2016;9:580-593. [PMID: 27366225 DOI: 10.1177/1756283X16637819] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 8.7] [Reference Citation Analysis]
496 Spencer M, Gupta A, Dam LV, Shannon C, Menees S, Chey WD. Artificial Sweeteners: A Systematic Review and Primer for Gastroenterologists. J Neurogastroenterol Motil 2016;22:168-80. [PMID: 26932837 DOI: 10.5056/jnm15206] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
497 Gibson PR, Varney JE, Muir JG. Diet Therapy for Irritable Bowel Syndrome: Is a Diet Low in FODMAPS Really Similar in Efficacy to Traditional Dietary Advice? Gastroenterology 2016;150:1046-7. [DOI: 10.1053/j.gastro.2015.10.053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
498 Rao SS, Rattanakovit K, Patcharatrakul T. Diagnosis and management of chronic constipation in adults. Nat Rev Gastroenterol Hepatol. 2016;13:295-305. [PMID: 27033126 DOI: 10.1038/nrgastro.2016.53] [Cited by in Crossref: 133] [Cited by in F6Publishing: 128] [Article Influence: 22.2] [Reference Citation Analysis]
499 Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, Niesler B, Quigley EM, Rajilić-Stojanović M, Schemann M, Schwille-Kiuntke J, Simren M, Zipfel S, Spiller RC. Irritable bowel syndrome. Nat Rev Dis Primers 2016;2:16014. [PMID: 27159638 DOI: 10.1038/nrdp.2016.14] [Cited by in Crossref: 338] [Cited by in F6Publishing: 394] [Article Influence: 56.3] [Reference Citation Analysis]
500 Prichard R, Rossi M, Muir J, Yao C, Whelan K, Lomer M. Fermentable oligosaccharide, disaccharide, monosaccharide and polyol content of foods commonly consumed by ethnic minority groups in the United Kingdom. International Journal of Food Sciences and Nutrition 2016;67:383-90. [DOI: 10.3109/09637486.2016.1163328] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
501 Mazzawi T, El-Salhy M. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance. Int J Mol Med. 2016;37:1247-1253. [PMID: 26987104 DOI: 10.3892/ijmm.2016.2523] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
502 Philpott H, Yu S, Rao S. It's All in the Mix: Diagnosis and Management of Food Intolerance. Clin Gastroenterol Hepatol 2016;14:1221-2. [PMID: 26968464 DOI: 10.1016/j.cgh.2016.03.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
503 Camilleri M. High-Fat Diet, Dysbiosis, and Gastrointestinal and Colonic Transit: Is There a Missing Link? Cell Mol Gastroenterol Hepatol 2016;2:257-8. [PMID: 28174717 DOI: 10.1016/j.jcmgh.2016.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
504 Zia J, Schroeder J, Munson S, Fogarty J, Nguyen L, Barney P, Heitkemper M, Ladabaum U. Feasibility and Usability Pilot Study of a Novel Irritable Bowel Syndrome Food and Gastrointestinal Symptom Journal Smartphone App. Clin Transl Gastroenterol 2016;7:e147. [PMID: 26938478 DOI: 10.1038/ctg.2016.9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
505 Zugasti Murillo A, Estremera Arévalo F, Petrina Jáuregui E. Dieta pobre en FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) en el síndrome de intestino irritable: indicación y forma de elaboración. Endocrinología y Nutrición 2016;63:132-8. [DOI: 10.1016/j.endonu.2015.10.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
506 Aziz I, Dwivedi K, Sanders DS. From coeliac disease to noncoeliac gluten sensitivity; should everyone be gluten free?: . Current Opinion in Gastroenterology 2016;32:120-7. [DOI: 10.1097/mog.0000000000000248] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
507 Chey WD. Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome. American Journal of Gastroenterology 2016;111:366-71. [DOI: 10.1038/ajg.2016.12] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
508 Staudacher HM, Whelan K. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. Proc Nutr Soc. 2016;75:306-318. [PMID: 26908093 DOI: 10.1017/s0029665116000021] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 8.7] [Reference Citation Analysis]
509 Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol 2016; 22(7): 2219-2241 [PMID: 26900286 DOI: 10.3748/wjg.v22.i7.2219] [Cited by in CrossRef: 188] [Cited by in F6Publishing: 152] [Article Influence: 31.3] [Reference Citation Analysis]
510 Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016;. [PMID: 27144627 DOI: 10.1053/j.gastro.2016.02.031] [Cited by in Crossref: 1039] [Cited by in F6Publishing: 865] [Article Influence: 173.2] [Reference Citation Analysis]
511 Barbara G, Feinle-Bisset C, Ghoshal UC, Quigley EM, Santos J, Vanner S, Vergnolle N, Zoetendal EG. The Intestinal Microenvironment and Functional Gastrointestinal Disorders. Gastroenterology. 2016;150:1305-1318. [PMID: 27144620 DOI: 10.1053/j.gastro.2016.02.028] [Cited by in Crossref: 134] [Cited by in F6Publishing: 132] [Article Influence: 22.3] [Reference Citation Analysis]
512 Chumpitazi BP, Shulman RJ. Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome. Mol Cell Pediatr 2016;3:11. [PMID: 26883355 DOI: 10.1186/s40348-016-0036-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
513 Lacy BE. Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med. 2016;9:7-17. [PMID: 26929659 DOI: 10.2147/ijgm.s93698] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
514 Lacy BE. Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med. 2016;9:7-17. [PMID: 26929659 DOI: 10.2147/ijgm] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
515 Teruel C, Garrido E, Mesonero F. Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther 2016; 7(1): 78-90 [PMID: 26855814 DOI: 10.4292/wjgpt.v7.i1.78] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
516 Kim JH. Diet and Nutritional Management in Functional Gastrointestinal Disorder: Irritable Bowel Syndrome. Korean J Med 2016;90:105-10. [DOI: 10.3904/kjm.2016.90.2.105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
517 Molina-infante J, Serra J, Fernandez-bañares F, Mearin F. The low-FODMAP diet for irritable bowel syndrome: Lights and shadows. Gastroenterología y Hepatología 2016;39:55-65. [DOI: 10.1016/j.gastrohep.2015.07.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
518 Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9:318-331. [PMID: 25918261 DOI: 10.5009/gnl14344] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 14.3] [Reference Citation Analysis]
519 Marie I, Leroi AM, Gourcerol G, Levesque H, Ménard JF, Ducrotte P. Fructose Malabsorption in Systemic Sclerosis. Medicine (Baltimore) 2015;94:e1601. [PMID: 26426642 DOI: 10.1097/MD.0000000000001601] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
520 De Giorgio R, Volta U, Gibson PR. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut 2016;65:169-78. [PMID: 26078292 DOI: 10.1136/gutjnl-2015-309757] [Cited by in Crossref: 125] [Cited by in F6Publishing: 104] [Article Influence: 20.8] [Reference Citation Analysis]
521 Parfenov AI, Albulova EA, Ruchkina IN. Irritable bowel syndrome in the light of Rome consensus III (2006): 10 years later. Ter arkh 2016;88:4. [DOI: 10.17116/terarkh20168824-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
522 Aziz I, Trott N, Briggs R, North JR, Hadjivassiliou M, Sanders DS. Efficacy of a Gluten-Free Diet in Subjects With Irritable Bowel Syndrome-Diarrhea Unaware of Their HLA-DQ2/8 Genotype. Clin Gastroenterol Hepatol. 2016;14:696-703.e1. [PMID: 26748221 DOI: 10.1016/j.cgh.2015.12.031] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 10.0] [Reference Citation Analysis]
523 Moloney RD, Johnson AC, O’Mahony SM, Dinan TG, Greenwood-Van Meerveld B, Cryan JF. Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome. CNS Neurosci Ther. 2016;22:102-117. [PMID: 26662472 DOI: 10.1111/cns.12490] [Cited by in Crossref: 143] [Cited by in F6Publishing: 156] [Article Influence: 20.4] [Reference Citation Analysis]
524 Karkar R, Zia J, Vilardaga R, Mishra SR, Fogarty J, Munson SA, Kientz JA. A framework for self-experimentation in personalized health. J Am Med Inform Assoc 2016;23:440-8. [PMID: 26644399 DOI: 10.1093/jamia/ocv150] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 8.7] [Reference Citation Analysis]
525 Berry RC, Novak P, Withrow N, Schmidt B, Rarback S, Feucht S, Criado KK, Sharp WG. Nutrition Management of Gastrointestinal Symptoms in Children with Autism Spectrum Disorder: Guideline from an Expert Panel. Journal of the Academy of Nutrition and Dietetics 2015;115:1919-27. [DOI: 10.1016/j.jand.2015.05.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
526 Mazzawi T, Hausken T, Gundersen D, El-Salhy M. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. Eur J Clin Nutr. 2016;70:175-181. [PMID: 26603880 DOI: 10.1038/ejcn.2015.191] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
527 Litleskare S, Wensaas KA, Eide GE, Hanevik K, Kahrs GE, Langeland N, Rortveit G. Perceived food intolerance and irritable bowel syndrome in a population 3 years after a giardiasis-outbreak: a historical cohort study. BMC Gastroenterol 2015;15:164. [PMID: 26585714 DOI: 10.1186/s12876-015-0393-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
528 Yoon SR, Lee JH, Lee JH, Na GY, Lee KH, Lee YB, Jung GH, Kim OY. Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial. Nutr J. 2015;14:116. [PMID: 26530312 DOI: 10.1186/s12937-015-0106-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
529 Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, Simrén M. Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial. Gastroenterology 2015;149:1399-1407.e2. [DOI: 10.1053/j.gastro.2015.07.054] [Cited by in Crossref: 300] [Cited by in F6Publishing: 313] [Article Influence: 42.9] [Reference Citation Analysis]
530 Noelting J, Dibaise JK. Mechanisms Of Fructose Absorption. Clinical and Translational Gastroenterology 2015;6:e120. [DOI: 10.1038/ctg.2015.50] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
531 Chumpitazi BP, Shulman RJ. Letter: avoid FODMAPs or follow simple tips--authors' reply. Aliment Pharmacol Ther 2015;42:1330. [PMID: 26510543 DOI: 10.1111/apt.13420] [Reference Citation Analysis]
532 Philpott H, Nandurkar S, Lubel J, Gibson PR. Food, fibre, bile acids and the pelvic floor: An integrated low risk low cost approach to managing irritable bowel syndrome. World J Gastroenterol 2015; 21(40): 11379-11386 [PMID: 26525925 DOI: 10.3748/wjg.v21.i40.11379] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
533 Iacovou M, Tan V, Muir JG, Gibson PR. The Low FODMAP Diet and Its Application in East and Southeast Asia. J Neurogastroenterol Motil. 2015;21:459-470. [PMID: 26350937 DOI: 10.5056/jnm15111] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
534 Deng Y, Misselwitz B, Dai N, Fox M. Lactose Intolerance in Adults: Biological Mechanism and Dietary Management. Nutrients. 2015;7:8020-8035. [PMID: 26393648 DOI: 10.3390/nu7095380] [Cited by in Crossref: 153] [Cited by in F6Publishing: 124] [Article Influence: 21.9] [Reference Citation Analysis]
535 El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T. The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. Nutr J. 2015;14:92. [PMID: 26345589 DOI: 10.1186/s12937-015-0080-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
536 Branchi F, Aziz I, Conte D, Sanders DS. Noncoeliac gluten sensitivity: a diagnostic dilemma. Current Opinion in Clinical Nutrition and Metabolic Care 2015;18:508-14. [DOI: 10.1097/mco.0000000000000207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
537 Vazquez-roque M, Oxentenko AS. Nonceliac Gluten Sensitivity. Mayo Clinic Proceedings 2015;90:1272-7. [DOI: 10.1016/j.mayocp.2015.07.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
538 Ringel-Kulka T, Choi CH, Temas D, Kim A, Maier DM, Scott K, Galanko JA, Ringel Y. Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome. Am J Gastroenterol. 2015;110:1339-1346. [PMID: 26303129 DOI: 10.1038/ajg.2015.220] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 9.0] [Reference Citation Analysis]
539 Miller R. New frontiers in fibre. Nutrition Bulletin 2015;40:247-52. [DOI: 10.1111/nbu.12160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
540 Spiller R, Pélerin F, Cayzeele Decherf A, Maudet C, Housez B, Cazaubiel M, Jüsten P. Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterol J. 2016;4:353-362. [PMID: 27403301 DOI: 10.1177/2050640615602571] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
541 Moayyedi P, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Ford AC. The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review. Clin Transl Gastroenterol. 2015;6:e107. [PMID: 26291435 DOI: 10.1038/ctg.2015.21] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
542 Mujagic Z, Keszthelyi D, Aziz Q, Reinisch W, Quetglas EG, De Leonardis F, Segerdahl M, Masclee AA. Systematic review: instruments to assess abdominal pain in irritable bowel syndrome. Aliment Pharmacol Ther 2015;42:1064-81. [PMID: 26290286 DOI: 10.1111/apt.13378] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
543 Pérez y López N, Torres-López E, Zamarripa-Dorsey F. Clinical response in Mexican patients with irritable bowel syndrome treated with a low diet low in fermentable carbohydrates (FODMAP).Rev Gastroenterol Mex. 2015;80:180-185. [PMID: 26300323 DOI: 10.1016/j.rgmx.2015.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.1] [Reference Citation Analysis]
544 Chumpitazi BP, Shulman RJ. Editorial: predicting response to a low FODMAP diet in children--authors' reply. Aliment Pharmacol Ther 2015;42:776. [PMID: 26278562 DOI: 10.1111/apt.13336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
545 . Does a low FODMAP diet help IBS?:. DTB 2015;53:93-6. [DOI: 10.1136/dtb.2015.8.0346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
546 Kim HJ. What is the FODMAP? Korean J Med 2015;89:179-85. [DOI: 10.3904/kjm.2015.89.2.179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
547 Gaesser GA, Angadi SS. Navigating the gluten-free boom. Journal of the American Academy of Physician Assistants 2015;28:1-7. [DOI: 10.1097/01.jaa.0000469434.67572.a4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
548 Ferrua MJ, Singh RP. Computational modelling of gastric digestion: current challenges and future directions. Current Opinion in Food Science 2015;4:116-23. [DOI: 10.1016/j.cofs.2015.06.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
549 Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol. 2015;31:69-75. [PMID: 25394236 DOI: 10.1097/mog.0000000000000139] [Cited by in Crossref: 586] [Cited by in F6Publishing: 631] [Article Influence: 83.7] [Reference Citation Analysis]
550 Hornby PJ. Drug discovery approaches to irritable bowel syndrome. Expert Opinion on Drug Discovery 2015;10:809-24. [DOI: 10.1517/17460441.2015.1049528] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
551 Elli L, Roncoroni L, Bardella MT. Non-celiac gluten sensitivity: Time for sifting the grain. World J Gastroenterol 2015; 21(27): 8221-8226 [PMID: 26217073 DOI: 10.3748/wjg.v21.i27.8221] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
552 Singh P, Staller K, Barshop K, Dai E, Newman J, Yoon S, Castel S, Kuo B. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. World J Gastroenterol 2015; 21(26): 8103-8109 [PMID: 26185382 DOI: 10.3748/wjg.v21.i26.8103] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
553 Wolf WA, Kiraly LN, Ireton-jones C. Incorporating FODMAP Dietary Restrictions: Help or Hype? Curr Nutr Rep 2015;4:214-9. [DOI: 10.1007/s13668-015-0131-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
554 El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2015; 21(25): 7621-7636 [PMID: 26167065 DOI: 10.3748/wjg.v21.i25.7621] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 61] [Article Influence: 9.3] [Reference Citation Analysis]
555 Lövdahl J, Ringström G, Agerforz P, Törnblom H, Simrén M. Nurse-Administered, Gut-Directed Hypnotherapy in IBS: Efficacy and Factors Predicting a Positive Response. Am J Clin Hypn 2015;58:100-14. [PMID: 26046719 DOI: 10.1080/00029157.2015.1030492] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
556 Pérez y López N, Torres-lópez E, Zamarripa-dorsey F. Clinical response in Mexican patients with irritable bowel syndrome treated with a low diet low in fermentable carbohydrates (FODMAP). Revista de Gastroenterología de México (English Edition) 2015;80:180-5. [DOI: 10.1016/j.rgmxen.2015.08.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
557 Oshima T, Miwa H. Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World. J Neurogastroenterol Motil. 2015;21:320-329. [PMID: 26095436 DOI: 10.5056/jnm14165] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 14.9] [Reference Citation Analysis]
558 Aziz I, Hadjivassiliou M, Sanders DS. The spectrum of noncoeliac gluten sensitivity. Nat Rev Gastroenterol Hepatol. 2015;12:516-526. [PMID: 26122473 DOI: 10.1038/nrgastro.2015.107] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
559 Jin H, Liu J, Foreman RD, Chen JD, Yin J. Electrical neuromodulation at acupoint ST36 normalizes impaired colonic motility induced by rectal distension in dogs. Am J Physiol Gastrointest Liver Physiol. 2015;309:G368-G376. [PMID: 26113299 DOI: 10.1152/ajpgi.00467.2014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
560 Chumpitazi BP, Cope JL, Hollister EB, Tsai CM, McMeans AR, Luna RA, Versalovic J, Shulman RJ. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther. 2015;42:418-427. [PMID: 26104013 DOI: 10.1111/apt.13286] [Cited by in Crossref: 228] [Cited by in F6Publishing: 212] [Article Influence: 32.6] [Reference Citation Analysis]
561 Shepherd SJ, Halmos E, Glance S. The role of FODMAPs in irritable bowel syndrome. Curr Opin Clin Nutr Metab Care. 2014;17:605-609. [PMID: 25255126 DOI: 10.1097/mco.0000000000000116] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
562 Furnari M, de Bortoli N, Martinucci I, Bodini G, Revelli M, Marabotto E, Moscatelli A, Del Nero L, Savarino E, Giannini EG, Savarino V. Optimal management of constipation associated with irritable bowel syndrome. Ther Clin Risk Manag 2015;11:691-703. [PMID: 26028974 DOI: 10.2147/TCRM.S54298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
563 Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr 2016;55:897-906. [DOI: 10.1007/s00394-015-0922-1] [Cited by in Crossref: 179] [Cited by in F6Publishing: 178] [Article Influence: 25.6] [Reference Citation Analysis]
564 Osicka T, Kothe E, Ricciardelli L. A systematic review of adherence to restricted diets in people with functional bowel disorders. Appetite 2015;92:143-55. [PMID: 25979567 DOI: 10.1016/j.appet.2015.05.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
565 Berg LK, Fagerli E, Myhre AO, Florholmen J, Goll R. Self-reported dietary fructose intolerance in irritable bowel syndrome: Proposed diagnostic criteria. World J Gastroenterol 2015; 21(18): 5677-5684 [PMID: 25987795 DOI: 10.3748/wjg.v21.i18.5677] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
566 Laskaratos F, Goodkin O, Thoua NM, Murray CD. Irritable bowel syndrome. Medicine 2015;43:266-70. [DOI: 10.1016/j.mpmed.2015.02.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
567 Ontiveros N, Hardy MY, Cabrera-Chavez F. Assessing of Celiac Disease and Nonceliac Gluten Sensitivity. Gastroenterol Res Pract. 2015;2015:723954. [PMID: 26064097 DOI: 10.1155/2015/723954] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
568 Talley NJ, Holtmann G, Walker MM. Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. J Gastroenterol. 2015;50:601-613. [PMID: 25917563 DOI: 10.1007/s00535-015-1076-x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
569 Cassell B, Gyawali CP, Kushnir VM, Gott BM, Nix BD, Sayuk GS. Beliefs about GI medications and adherence to pharmacotherapy in functional GI disorder outpatients. Am J Gastroenterol 2015;110:1382-7. [PMID: 25916226 DOI: 10.1038/ajg.2015.132] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
570 Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther. 2015;41:1256-1270. [PMID: 25903636 DOI: 10.1111/apt.13167] [Cited by in Crossref: 178] [Cited by in F6Publishing: 145] [Article Influence: 25.4] [Reference Citation Analysis]
571 El-Salhy M, Gundersen D. Diet in irritable bowel syndrome. Nutr J. 2015;14:36. [PMID: 25880820 DOI: 10.1186/s12937-015-0022-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
572 Whigham L, Joyce T, Harper G, Irving PM, Staudacher HM, Whelan K, Lomer MCE. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J Hum Nutr Diet 2015;28:687-96. [DOI: 10.1111/jhn.12318] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
573 Peters SL, Muir JG, Gibson PR. Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther 2015;41:1104-15. [DOI: 10.1111/apt.13202] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 7.9] [Reference Citation Analysis]
574 Chassany O, Tugaut B, Marrel A, Guyonnet D, Arbuckle R, Duracinsky M, Whorwell PJ, Azpiroz F. The Intestinal Gas Questionnaire: development of a new instrument for measuring gas-related symptoms and their impact on daily life. Neurogastroenterol Motil 2015;27:885-98. [DOI: 10.1111/nmo.12565] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
575 Marchioni Beery RM, Birk JW. Wheat-related disorders reviewed: making a grain of sense. Expert Review of Gastroenterology & Hepatology 2015;9:851-64. [DOI: 10.1586/17474124.2015.1032252] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
576 Mazzawi T, Gundersen D, Hausken T, El-Salhy M. Increased chromogranin a cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance. Gastroenterol Res Pract. 2015;823897. [PMID: 25918524 DOI: 10.1155/2015/823897] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
577 Good L, Rosario R, Panas R. New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin. World J Gastroenterol 2015; 21(11): 3361-3366 [PMID: 25805945 DOI: 10.3748/wjg.v21.i11.3361] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
578 Tovoli F, Masi C, Guidetti E, Negrini G, Paterini P, Bolondi L. Clinical and diagnostic aspects of gluten related disorders. World J Clin Cases 2015;3:275-84. [PMID: 25789300 DOI: 10.12998/wjcc.v3.i3.275] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
579 Lacy BE. The Science, Evidence, and Practice of Dietary Interventions in Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 2015;13:1899-906. [PMID: 25769411 DOI: 10.1016/j.cgh.2015.02.043] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
580 Molina-infante J, Santolaria S, Sanders DS, Fernández-bañares F. Systematic review: noncoeliac gluten sensitivity. Aliment Pharmacol Ther 2015;41:807-20. [DOI: 10.1111/apt.13155] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 9.0] [Reference Citation Analysis]
581 Deiana S, Gabbani T, Bagnoli S, Annese V. Emerging drug for diarrhea predominant irritable bowel syndrome. Expert Opin Emerg Drugs 2015;20:247-61. [PMID: 25732091 DOI: 10.1517/14728214.2015.1013935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
582 Thomas A, Quigley EM. Diet and irritable bowel syndrome: . Current Opinion in Gastroenterology 2015;31:166-71. [DOI: 10.1097/mog.0000000000000158] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
583 Mansueto P, Seidita A, D’alcamo A, Carroccio A. Role of FODMAPs in Patients With Irritable Bowel Syndrome. Nutr Clin Pract 2015;30:665-82. [DOI: 10.1177/0884533615569886] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
584 Kucek LK, Veenstra LD, Amnuaycheewa P, Sorrells ME. A Grounded Guide to Gluten: How Modern Genotypes and Processing Impact Wheat Sensitivity. Compr Rev Food Sci Food Saf 2015;14:285-302. [PMID: 33401796 DOI: 10.1111/1541-4337.12129] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
585 Gibson PR, Varney J, Malakar S, Muir JG. Food components and irritable bowel syndrome. Gastroenterology 2015; 148: 1158-74. e4. [PMID: 25680668 DOI: 10.1053/j.gastro.2015.02.005] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 11.3] [Reference Citation Analysis]
586 Keller J, Andresen V. Darmmikrobiom und funktionelle gastrointestinale Erkrankungen. Gastroenterologe 2015;10:102-10. [DOI: 10.1007/s11377-014-0964-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
587 Halmos EP, Gibson PR. Dietary management of IBD--insights and advice. Nat Rev Gastroenterol Hepatol. 2015;12:133-146. [PMID: 25645969 DOI: 10.1038/nrgastro.2015.11] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 7.4] [Reference Citation Analysis]
588 Koretz RL. JPEN Journal Club 10. Blinding. JPEN J Parenter Enteral Nutr 2014;39:228-30. [DOI: 10.1177/0148607114552849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
589 Rajilić-Stojanović M, Jonkers DM, Salonen A, Hanevik K, Raes J, Jalanka J, de Vos WM, Manichanh C, Golic N, Enck P, Philippou E, Iraqi FA, Clarke G, Spiller RC, Penders J. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol 2015;110:278-87. [PMID: 25623659 DOI: 10.1038/ajg.2014.427] [Cited by in Crossref: 198] [Cited by in F6Publishing: 210] [Article Influence: 28.3] [Reference Citation Analysis]
590 Ahmad OF, Akbar A. Dietary treatment of irritable bowel syndrome. Br Med Bull 2015;113:83-90. [PMID: 25601299 DOI: 10.1093/bmb/ldu039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
591 Nagaraja V, McMahan ZH, Getzug T, Khanna D. Management of gastrointestinal involvement in scleroderma. Curr Treatm Opt Rheumatol. 2015;1:82-105. [PMID: 26005632 DOI: 10.1007/s40674-014-0005-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
592 Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015;64:93-100. [PMID: 25016597 DOI: 10.1136/gutjnl-2014-307264] [Cited by in Crossref: 425] [Cited by in F6Publishing: 374] [Article Influence: 60.7] [Reference Citation Analysis]
593 Muir JG, Yao CK, Gibson PG. Functional short-chain carbohydrates (prebiotics) in the diet to improve the microbiome and health of the gastrointestinal tract. Anim Prod Sci 2015;55:1376. [DOI: 10.1071/an15277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
594 Chogle A, Mintjens S, Saps M. Pediatric IBS: an overview on pathophysiology, diagnosis and treatment. Pediatr Ann. 2014;43:e76-e82. [PMID: 24716562 DOI: 10.3928/00904481-20140325-08] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
595 Lomer MCE. Review article: the aetiology, diagnosis, mechanisms and clinical evidence for food intolerance. Aliment Pharmacol Ther 2015;41:262-75. [DOI: 10.1111/apt.13041] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 8.6] [Reference Citation Analysis]
596 Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol 2015;12:36-49. [DOI: 10.1038/nrgastro.2014.200] [Cited by in Crossref: 117] [Cited by in F6Publishing: 116] [Article Influence: 14.6] [Reference Citation Analysis]
597 Carroccio A, Soresi M, D'Alcamo A, Sciumè C, Iacono G, Geraci G, Brusca I, Seidita A, Adragna F, Carta M, Mansueto P. Risk of low bone mineral density and low body mass index in patients with non-celiac wheat-sensitivity: a prospective observation study. BMC Med 2014;12:230. [PMID: 25430806 DOI: 10.1186/s12916-014-0230-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
598 Pedersen N, Andersen NN, Végh Z, Jensen L, Ankersen DV, Felding M, Simonsen MH, Burisch J, Munkholm P. Ehealth: Low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol 2014; 20(43): 16215-16226 [PMID: 25473176 DOI: 10.3748/wjg.v20.i43.16215] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 97] [Article Influence: 14.0] [Reference Citation Analysis]
599 Tojo R, Suárez A, Clemente MG, de los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P. Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis. World J Gastroenterol 2014; 20(41): 15163-15176 [PMID: 25386066 DOI: 10.3748/wjg.v20.i41.15163] [Cited by in CrossRef: 272] [Cited by in F6Publishing: 237] [Article Influence: 34.0] [Reference Citation Analysis]
600 Huamán JW, Felip A, Guedea E, Jansana M, Videla S, Saperas E. [The diet low in fermentable carbohydrates short chain and polyols improves symptoms in patients with functional gastrointestinal disorders in Spain]. Gastroenterol Hepatol. 2015;38:113-122. [PMID: 25458546 DOI: 10.1016/j.gastrohep.2014.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
601 Iovino P, Bucci C, Tremolaterra F, Santonicola A, Chiarioni G. Bloating and functional gastro-intestinal disorders: Where are we and where are we going? World J Gastroenterol 2014; 20(39): 14407-14419 [PMID: 25339827 DOI: 10.3748/wjg.v20.i39.14407] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
602 Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Irritable bowel syndrome: A microbiome-gut-brain axis disorder? World J Gastroenterol 2014; 20(39): 14105-14125 [PMID: 25339800 DOI: 10.3748/wjg.v20.i39.14105] [Cited by in CrossRef: 199] [Cited by in F6Publishing: 162] [Article Influence: 24.9] [Reference Citation Analysis]
603 Spencer M, Chey WD, Eswaran S. Dietary Renaissance in IBS: Has Food Replaced Medications as a Primary Treatment Strategy? Curr Treat Options Gastroenterol 2014;12:424-40. [PMID: 25219357 DOI: 10.1007/s11938-014-0031-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
604 Kendig DM, Hurst NR, Bradley ZL, Mahavadi S, Kuemmerle JF, Lyall V, DeSimone J, Murthy KS, Grider JR. Activation of the umami taste receptor (T1R1/T1R3) initiates the peristaltic reflex and pellet propulsion in the distal colon. Am J Physiol Gastrointest Liver Physiol 2014;307:G1100-7. [PMID: 25324508 DOI: 10.1152/ajpgi.00251.2014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
605 Turnbull JL, Adams HN, Gorard DA. Review article: the diagnosis and management of food allergy and food intolerances. Aliment Pharmacol Ther 2015;41:3-25. [DOI: 10.1111/apt.12984] [Cited by in Crossref: 142] [Cited by in F6Publishing: 109] [Article Influence: 17.8] [Reference Citation Analysis]
606 Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Quigley EM; Task Force on the Management of Functional Bowel Disorders. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 2014;109 Suppl 1:S2-26; quiz S27. [PMID: 25091148 DOI: 10.1038/ajg.2014.187] [Cited by in Crossref: 350] [Cited by in F6Publishing: 328] [Article Influence: 43.8] [Reference Citation Analysis]
607 Fedewa A, Rao SS. Dietary fructose intolerance, fructan intolerance and FODMAPs. Curr Gastroenterol Rep. 2014;16:370. [PMID: 24357350 DOI: 10.1007/s11894-013-0370-0] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
608 Mullin GE, Shepherd SJ, Chander Roland B, Ireton-Jones C, Matarese LE. Irritable bowel syndrome: contemporary nutrition management strategies. JPEN J Parenter Enteral Nutr. 2014;38:781-799. [PMID: 25085503 DOI: 10.1177/0148607114545329] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
609 Fritscher-Ravens A, Schuppan D, Ellrichmann M, Schoch S, Röcken C, Brasch J, Bethge J, Böttner M, Klose J, Milla PJ. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2014;147:1012-20.e4. [PMID: 25083606 DOI: 10.1053/j.gastro.2014.07.046] [Cited by in Crossref: 166] [Cited by in F6Publishing: 173] [Article Influence: 20.8] [Reference Citation Analysis]
610 Cuomo R, Andreozzi P, Zito FP, Passananti V, Carlo GD, Sarnelli G. Irritable bowel syndrome and food interaction. World J Gastroenterol 2014; 20(27): 8837-8845 [PMID: 25083057 DOI: 10.3748/wjg.v20.i27.8837] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
611 Aziz I, Sanders DS. Patients who avoid wheat and gluten: is that health or lifestyle? Dig Dis Sci 2014;59:1080-2. [PMID: 24595656 DOI: 10.1007/s10620-014-3083-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
612 Lee J. Sorbitol, Rubus fruit, and misconception. Food Chem 2015;166:616-22. [PMID: 25053101 DOI: 10.1016/j.foodchem.2014.06.073] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
613 Camilleri M, Acosta A. Re: Halmos et al, A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome. Gastroenterology 2014;146:1829-30. [DOI: 10.1053/j.gastro.2014.01.071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
614 Molina-infante J, Santolaria S, Montoro M, Esteve M, Fernández-bañares F. Sensibilidad al gluten no celiaca: una revisión crítica de la evidencia actual. Gastroenterología y Hepatología 2014;37:362-71. [DOI: 10.1016/j.gastrohep.2014.01.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
615 Sharma A, Ghoshal UC. Low FODMAP Diet in the Treatment of Irritable Bowel Syndrome: Is It the End of the Road or the Beginning of a Journey? Gastroenterology 2014;146:1830. [DOI: 10.1053/j.gastro.2014.02.059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
616 Lundin KE. Non-celiac gluten sensitivity - why worry? BMC Med. 2014;12:86. [PMID: 24885490 DOI: 10.1186/1741-7015-12-86] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
617 Vanuytsel T, Tack JF, Boeckxstaens GE. Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol. 2014;49:1193-1205. [PMID: 24845149 DOI: 10.1007/s00535-014-0966-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
618 Sung HY, Kim YS. Fructose Malabsorption in Patients With Irritable Bowel Syndrome-like Symptoms: What Is the Role in the Pathogenesis and Clinical Implication? J Neurogastroenterol Motil 2014;20:135-7. [PMID: 24840365 DOI: 10.5056/jnm.2014.20.2.135] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
619 Tuck CJ, Muir JG, Barrett JS, Gibson PR. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2014;8:819-834. [PMID: 24830318 DOI: 10.1586/17474124.2014.917956] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 9.0] [Reference Citation Analysis]
620 Prell C, Koletzko B. Restriktive Diäten: Gefahr einer Fehlernährung und Möglichkeiten der Prävention. Monatsschr Kinderheilkd 2014;162:503-10. [DOI: 10.1007/s00112-013-3070-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
621 Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 2014;11:497-505. [PMID: 24751910 DOI: 10.1038/nrgastro.2014.40] [Cited by in Crossref: 213] [Cited by in F6Publishing: 201] [Article Influence: 26.6] [Reference Citation Analysis]
622 Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol. 2014;49:785-798. [PMID: 24652102 DOI: 10.1007/s00535-014-0953-z] [Cited by in Crossref: 139] [Cited by in F6Publishing: 124] [Article Influence: 17.4] [Reference Citation Analysis]
623 Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014;146:1500-1512. [PMID: 24583088 DOI: 10.1053/j.gastro.2014.02.037] [Cited by in Crossref: 234] [Cited by in F6Publishing: 223] [Article Influence: 29.3] [Reference Citation Analysis]
624 Konturek PC. In reply. Dtsch Arztebl Int 2014;111:149. [PMID: 24661588 DOI: 10.3238/arztebl.2014.0149] [Reference Citation Analysis]
625 Azpiroz F, Hernandez C, Guyonnet D, Accarino A, Santos J, Malagelada JR, Guarner F. Effect of a low-flatulogenic diet in patients with flatulence and functional digestive symptoms. Neurogastroenterol Motil. 2014;26:779-785. [PMID: 24548289 DOI: 10.1111/nmo.12324] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
626 Staudacher HM, Irving PM, Lomer MC, Whelan K. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat Rev Gastroenterol Hepatol. 2014;11:256-266. [PMID: 24445613 DOI: 10.1038/nrgastro.2013.259] [Cited by in Crossref: 161] [Cited by in F6Publishing: 129] [Article Influence: 20.1] [Reference Citation Analysis]
627 Vaiopoulou A, Karamanolis G, Psaltopoulou T, Karatzias G, Gazouli M. Molecular basis of the irritable bowel syndrome. World J Gastroenterol 2014; 20(2): 376-383 [PMID: 24574707 DOI: 10.3748/wjg.v20.i2.376] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
628 Kim JH, Sung I. Current Issues on Irritable Bowel Syndrome: Diet and Irritable Bowel Syndrome. Korean J Gastroenterol 2014;64:142. [DOI: 10.4166/kjg.2014.64.3.142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
629 Kanazawa M, Fukudo S. Relationship between infectious gastroenteritis and irritable bowel syndrome. Clin J Gastroenterol. 2014;7:14-18. [PMID: 26183503 DOI: 10.1007/s12328-013-0444-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
630 Simrén M. Diet as a therapy for irritable bowel syndrome: progress at last. Gastroenterology. 2014;146:10-12. [PMID: 24275241 DOI: 10.1053/j.gastro.2013.11.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]